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ABSTRACT
Candida albicans is an opportunistic fungal pathogen that may cause mucutaneous infection
and/or disseminated candidasis if the host defense system is impaired (such as those in HIV
patients). Cell surface of C. albicans is the frontier where initial interplay between host-pathogen
takes place and therefore is of great importance in understanding the mechanism of hostpathogen interaction. MALDI-TOF-MS analysis of intact fungal cells yielded mass signatures
for rapid species differentiation, strain grouping and yeast morphogenesis monitoring.

Cell surface biotinylations at low temperature (4°C), enzymatic digestion of the intact fungal cell
surface proteins (“whole cell shaving”), biotin-avidin affinity enrichment of biotinylated
peptides, liquid chromatography mass spectrometry (LC-MS) based proteomic approach were
employed for unambiguous identification of cell wall/cell wall associated proteins and the
exposed peptide segments of these proteins. SILAC (Stable Isotope Labeling by Amino acids in
Cell Culture) based CWP quantification analyses were performed to monitor CWP accumulation
level change in response to hyphae induction. Information on surface exposed peptide segments
and regulation of cell wall/surface protein during morphogenesis provided new candidates to the
pool of potential peptide targets for protective vaccine development.

A New type of “fluorous” (fluorinated alkane) affinity gained popularity due to its low level nonspecific protein/peptide binding. Fluorous labeling reagents that target primary amine groups in
proteins/peptides were synthesized and characterized. The acid labile linker in the labeling
reagents allows cleavage of the bulky fluorous tag moiety and the long oligo ethylene glycol
(OEG) spacer after fluorous affinity purification. Upon collision induced decomposition, the

xiv

labeled peptide ion yielded a characteristic fragment that could be retrieved from the residual
portion of fluorous affinity tag, and serve as a marker to indicate that the relevant peptide had
been successfully labeled. Results showed that both the protein/peptide labeling and affinity
enrichment/separation process were highly efficient.

Keywords
Candida albicans, Yeast differentiation, MALDI-TOF MS, Fluorous labeling reagent, LC-MS,
Cell surface proteome, Surface biotinylation, SILAC
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CHAPTER 1

Introduction

1.1 Overview of Candida albicans
C. albicans is a member of yeast kingdom that possesses basic biological features for the yeast
species such as a singular cell with an oval shape, reproduction by budding or fission. However,
its opportunistic pathogenicity distinguished C. albican from its benign relative Saccharomyces
cerevisiae that is commonly used as baker’s yeast in our daily lives. C. albicans commensally
exists in most healthy human populations and can usually be observed in the oral cavity, gastrointenstinal and urogential tracts. The tipping point of the balance relies on both the host immunosystem and the fungal traits. This facultative pathogen may turn into a pathogenic agent of
infection if the host defense system is impaired. The severity of the fungal infection, depending
on the nature and extent of the impairment of the host immune-system, can vary from superficial
mucocutaneous infections to life-threatening, invasive infection (124). Over the last few decades,
reports of human fungal infection have been increasing at an alarming rate worldwide (132),
especially in immuno-compromised patients like HIV infected individuals, patients undergoing
transplanting surgery, chemotherapy and other immuno-suppressed treatments (25, 45).
Candidiasis is now the fourth leading cause of nosocomial bloodstream infections in the US (83),
and for many years the overwhelming leading cause of this disease has been C. albicans.
C. albicans is a dimorphic organism, which has the ability to transform singular budding yeast to
filamentous hyphae cells under environmental factors such as growth temperature at 37°C, serum
medium and near neutral pH (9). This morphogenic development is recognized as a key
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virulence factor of the fungal species during infection as it enables attacks on host cells either
through epithelium invasion or endothelium barrier breaching (29) (82). As a matter of fact, it
was shown that non-filamentous mutants were avirulent in murine models (88). One of the key
features during the morphological change from yeast to hyphae is the cell wall remodeling,
which is companied not only by composition change of cell wall but also by differential
regulations of cell wall proteins. Previous study showed that it was easier for C. albicans hyphae
cells to escape from the capture of mammalian macrophages than yeast cells (88). Information
on the quantitative change of cell wall protein expression level during the conversion may shed
lights on the path to understand what renders the hyphae more virulent compared to the yeast
form morphogenesis.

The cell surface is of critical consideration in the attempts to understand morphogenesis and
immunologic target identification, as the cell surface is the forefront where the initial contact
between host-fungus occurs and such contact may induce immune response from the host.
Understanding of the pathogen-host interaction may provide insight into the functional
mechanism of fungal invasion. Mechanisms by which C. albicans cause disease are still largely
unknown. Although progress has been made on identification of immunologic targets that can be
recognized by either antibodies or cell-mediated immune defenses (30) more information is
needed before immuno-approaches to prevention and treatment of candidiasis become a reality.

1.2 MALDI -TOF Mass Spectrometry
Matrix-assisted laser-desorption/ionization (MALDI) was first introduced in late 1980s by Karas,
Hillenkamp, (76) (78) and Tanaka (128). This revolutionary method for ionizing large molecules
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blazed new trails in the mass spectrometry field along with another parallel ionization technique,
electrospray ionization (ESI), ushered by Fenn (42). Since then both of these two techniques
have been the most successful ionizing methods for large bio-molecules such as proteins,
nucleotides, and carbohydrates. In MALDI, analytes are usually co-crystalized with certain types
of matrix, which transfer the absorbed large excess of laser energy (UV or IR wavelengths) to
the neighboring analyte molecules during the excitation process. A plum of ions was released
upon laser irradiation, accelerated by electrical potential and analyzed by a mass spectrometer as
illustrated in Figure 1.1.

Photochemical ionization (PI) (39) and cluster ionization (CI) (77) have been proposed as the
two major models for explaining the mechanism of MALDI process. Matrix molecules were
initially excited through energy pooling and multiphoton extraction from laser irradiation in the
PI model. Analyte ions were consequently generated after protons were transferred to the analyte
molecules. The PI model has been commonly accepted as the primary mechanism for MALDI ,
although it can not be applied to explain some experimental phenomena such as matrix
suppression effect (80) and “sweet spot” (87). Contrary to the PI model (39), the CI model (77)
redefined the origin of analyte ions by proposing a large protonated analyte cluster clouded with
excessive amount of matrix molecules. Singly charged analyte ions were released from the large
analyte-matrix cloud after “shaking off” neutral matrix molecules in gas phase. The ionization
process in the CI model is analogous to the solvent desolvation stepin ESI. However, the CI
model failed to explain why large biomolecules were singly charged in the gas phase while the
same type of molecules were multiply charged in ESI. Recently, Chen and co-workers (20)
proposed an energy transfer induced disproportionation (ETID) model which enabled them to
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Figure 1.1. Schematic overview of matrix-assisted laser desorption/ionization (MALDI).
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explain the observation of equal number of positive and negative analyte ions in MALDI.

Matrix selection plays pivotal roles in the success of MALDI analysis. Matrices are usually
aromatic compounds with low vapor pressure. Nicotinic acid (NA) was the first matrix applied in
ionizing proteins and peptides (78). A broad range of matrices have been surveyed to determine
if a compound is suitable for the ionization of a particular type of analyte molecule. For example,
picolinic acid (PA) and 3-hydroxypicolinic acid (HPA) have been used for oligonucleotides and
DNA analyses, (129) (140) 2,5-dihydroxybenzoic acid (DHB) for oligosaccharides, (127) αcyano-4-hydroxycinnamic acid (CHCA) for peptides (8), and sinapinic acid (SA) for proteins
(7). In addition to matrix selection, sample preparation is also an important factor for a
successful MALDI analysis. The typical molar ratio of matrix-to-analyte is kept between 500 : 1
and 5000 : 1, (62) in order to ensure a good signal-to-noise ratio while minimizing the “matrix
effect”. Also, co-crystallization of a mixture of analyte and matrix is critical in analysis.
Unevenly formed co-crystals can cause poor reproducibility due to the presence of “sweet spots”,
only from which good quality mass spectrum may be obtained. “Thin-layer” depositing
technique can improve the co-crystallization process by slow evaporation of low volatile solvents
such as acetone and acetonitrile (134). Upon irradiation by a focused laser beam, the matrix and
the analyte molecules embedded in the co-crystals leave the MALDI target plate and enter into
the gas phase in the form of a plume of ions and neutral molecules. Those singly charged ions
are then accelerated through an electronic potential field, separated on the basis of their
molecular weight and finally recorded at a mass detector.

1.3 Advantages and challenges in microbe identification by MALDI-TOF MS

5

World-wide infections caused by various microorganisms have been constant threats to human
health, even though progress had been made in combating those infections by new inventions in
medicine. Application of mass spectrometry based methods in microorganism detection has
been fueled by the advances in mass spectrometry instrumentation recently. Short analysis time
(a few minutes) is a major advantage of MS-based characterization of microorganism when
compared with other methods such as the classical polymerase chain reaction (PCR) based
approaches. Moreover, the MS-based methods usually do not pre-specify targets, whereas DNA
primer designs in PCR require predetermined targets. MS spectral data can be readily processed
and incorporated into a reference library, which can subsequently be searched to identify
unknown samples (67).

The first mass spectrometry based application for bacteria identification was reported in 1975 by
Anhalt et al (3), who demonstrated the feasibility of differentiating pathogenic bacterial species
via pyrolysis-mass spectrometry (Py-MS). Basile et al (6) reduced the analysis time of bacterial
samples to minutes by combining thermal hydrolysis and methylation step with Py-MS.
Characteristic mass spectra were also obtained through fast atom bombardment mass
spectrometry analysis of lysed bacteria (60). It was not until the late 1990s that MALDI and ESI
were introduced to generate mass spectral data for bacterial species (63) (24) and viral species
(34). Since then, MALDI-MS analyses of toxigenic and pathogenic bacteria were extensively
reported in the literature(58) (139) (64, 92, 121) (133, 141). Experimental factors that potentially
affect the quality and reproducibility of the mass spectra obtained from intact whole bacteria
cells were defined for identification and species differentiation (64). Bacterial species readily
yield abundant peaks in mass spectra without prior sample treatment. Several automated MALDI
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mass spectra comparison programs were also developed to facilitate rapid identification and
speciation of intact bacteria. Mathematical algorithms in automated spectra comparison
programs were usually based on a cross correlation between two mass spectra (5) or derived
from a statistical test of significance with reliance on specific bio-makers (38, 46, 67, 116).
Cluster analysis such as Phylogenetic Analysis Using Parsimony (PAUP*) had been employed to
compare the MALDI mass spectra of Aeromonas species and determine the relationships among
the analyzed species (35). Principle component analysis (PCA) is another popular multivariate
analysis which can be employed to extract features in dataset generated from mass spectra and
project each spectrum to a single spot on a PCA plot (57). Compared to ESI-MS, rapid MALDIMS analysis has several advantageous features: 1. there is no clogging problem in the ion source;
2. mostly singly charged ions simplify the acquired spectrum (32).

Compared to the growing number of bacterial analysis by MALDI, analysis of fungi was rarely
reported. A few reports in the literature showed varying degree of success (2, 21, 66, 86). If the
fungal cell wall is untreated, very few peaks appear on MALDI spectra intact fungal cells as a
result of low yield of medium size ions (5000 – 15000 Da). To address this problem, partial
disruption of cell wall matrix may be necessary. Cell wall digestion is one of the methods that
facilitate MALDI-MS analyses of fungal species (43). Other treatments such as strong acid
extraction and detergent solubilization have also been employed (43). These fungal cell wall
pretreatments were usually time consuming and not entirely compatible to MALDI-MS analysis
due to the suppression effect of detergents. Development of simple MS-friendly sample
treatment method is an important consideration in fungal analysis by MALDI-MS.
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1.4 Organization of the cell wall of C .albicans
The C. albicans cell wall is a rigid matrix that mainly consists of polysaccharides (about 8090%) represented by β-1,3 and β-1,6 glucans, chitin and mannan. Proteins (6-25%) and a small
amount of lipid (1 to 7%) are also integrated into the cell wall (19). The cell wall is partitioned
into several layers distinguished by different densities when studied by electron microscopy. Cell
wall of C. albicans is usually composed of three to eight layers (112). An electron-dense outer
layer space is mainly composed of mannoproteins, which can be detected by concana-valin A
(ConA) labeling (90) or specific antibody (69). The electron transparent inner layer is largely
composed of a net work of highly branched polysaccharides and a small number of proteins.
Yeast and hyphae forms share similar percent composition of the cell wall, although the relative
amounts of individual component differ significantly (15). The cell wall is highly dynamic and is
involved in almost all aspects of the biology and the interactions of this fungus with the host (18)
(19) while it maintains a balance between rigidity and plasticity. The rigidity of the cell wall
provides strong protection for the intracellular components against environmental stress, while
the plasticity allows the cell wall to adapt to different stages of development during
morphogenesis of yeast to hyphal forms or yeast to pseudohyphal forms. The rigidity of the cell
wall is largely attributed to β-glucans and chitin near the plasma membrane (74) (93, 110).

1.5 Cell wall proteins and their functions in C. albicans
Besides the role in maintaining the architecture of the wall, polysaccharides, the major
component of the cell wall, may also serve as ligands for receptor proteins from host immune
cells (33) (44, 52, 100). However, the protein population of the cell wall is more likely to
distinguish C. albicans as pathogenic yeast from non-pathogenic S.cerevisiae (124). The outer
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layer of the cell wall is replete with various mannoproteins, which are either covalently bound to
the inner layer of glucan/chitin networks through β-1,3 and/or β-1,6 linkage or loosely
associated with cell wall matrix (74, 110). There are two classes of covalently bound cell wall
proteins (CWPs): GPI (Glycosylphosphatidylinositol)-CWPs and Pir (Proteins with internal
repeats)-CWPs. GPI-CWPs are those proteins with C-termini linked to the reducing end of β-1,6
glucan chain via a phosphodiester bond, which is then integrated into a inner flexible network of
β-1,3 glucan chains or chitin chains (72, 81). In fungi, some of those GPI proteins are released
from the membrane and incorporated with the cell wall matrix (48, 56). The GPI-CWPs can be
extracted through hydrolysis of the phosphodiester bond using HF-pyridine. Pir-CWPs (130) are
linked directly to the network of β-1,3 glucan chains without any bridging from of β-1,6 glucan
and can be cleaved from the glucan chains by NaOH treatment(75, 99). Despite significant
amount of studies on GPI-CWPs and Pir-CWPs, information is very fragmentary on other CWPs
covalently bound either to β-1,3 glucan or chitin via uncharacterized linkages. Those proteins are
usually extracted through enzymatic treatment like Quantazyme (β-1,3 glucanase) and/or
exochitinase digestion in which by the polysaccharide moieties of the glycoproteins were
destroyed (110). Additionally, a large set of CWPs do not have strong attachment to the cell wall
matrix (or connected to the covalently bound CWPs merely through disulfide bond). Some of the
proteins related to the cell wall are viewed as secreted proteins (95) (84) because they are usually
also observed in culture medium. Hot sodium dodecyl sulfate (SDS) buffer containing reducing
reagents (such as dithiolthreitol) is commonly used to strip those noncovalently associated CWPs
from the cell wall matrix.
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Bona fide cell wall proteins are accepted as those that meet the following criteria (115): 1.
Proteins have a secretory motif (N-terminal secretion signal peptides). 2. Proteins have other
characteristic features such as GPI-binding motif or inner repeats in addition to their
glycosylation modifications. Based on these standards, hundreds of cell wall proteins in C.
albicans were predicted from ORFs analysis (31). This paradigm, however, has never been
challenged with the accumulating evidence of detected nonglycosylated proteins (37, 110) and/or
numerous proteins without signal motif on the surface (103). Therefore, the concept of cell wall
protein should be redefined based on experimental findings in order to accommodate those noncanonical wall proteins.

Even though the fungal cell wall is comprised of highly diverse proteins, five main functions
have been assigned to those CWPs. 1). Some proteins are involved in enzymatic degradation of
large molecules which could serve as a nutritional source. Other protein enzymes play roles in
maintaining the architecture of cell wall polymers by their involvement in the pathways of
polysaccharide degradation/synthesis;(19) 2). Some proteins are involved in initiating “crosstalk” with host cells. Adhesins are typical fimbriae mannoproteins that facilitate the attachment
of the fungal cell to host cell (epithelial, endothelial or platelets) through four major recognition
systems; (115) 3). Antigenicity is another important function shared by different cell wall
proteins from both yeast and hyphal cells (17). Those proteins with immunogenic motifs are
good candidates for vaccine development; 4). Certain cell wall proteins may contribute to
virulence factors on cell surface as evidenced by their involvement in pathogenesis (47).

10

1.6 ESI-MS based proteomic approach to studying cell surface of C. albicans and current
challenges
In this post-genomic era, advancement in proteomics has been fueled by the development of
versatile mass spectrometry instrumentation. The term “proteomics” was coined by Marc
Wilkins in 1994 (36, 138) with a notion of 2D gel based analysis of total protein expressed by a
genome. The extension of this concept, however, is far more comprehensive then its original
definition and still rapidly expanding driven by the demand for answering new questions arising
from biology studies. Proteomics is now related not only to protein sequencing and proteome
profiling in a certain compartment of an organism, but also to the study on the dynamic change
of protein accumulation levels under various conditions, post modifications of proteins and
protein-protein interactions. MS-oriented proteomics is undoubtedly the mainstream in studying
proteins in biological field that is benefited from discovery and development of protein
ionization techniques.

Two “soft” ionization techniques, ESI (42) and MALDI, (76) are most commonly employed
mass spectrometry based analyses of proteins and peptides. In ESI, high electric potential is
applied to analyte solution to form charged droplets. Attracted by a potential gradient and a
pressure gradient along the ion passage, the droplet undergoes a desolvation process, which leads
to downsize the droplet. The process continues by constant evaporation of the solvent (and ions
in some cases) until fully desolvated ions are formed. ESI-MS is usually coupled with liquid
chromatography (LC) to form an on-line LC-MS system that has become the most powerful
instrumentation for peptide sequencing in proteomics field (Figure 1.2.).
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Figure 1.2. Schematic presentation of liquid chromatography (LC)-mass spectrometry (MS)
analysis of a peptide mixture in positive mode.
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In most tandem mass spectrometry-based proteomic approaches, the proteins are chemically or
enzymatically digested to yield smaller peptides and these peptides are subsequently analyzed by
tandem mass spectrometry. Database searches are performed on the tandem mass spectra of
peptides to determine the peptides’ amino acid sequences, and protein identification is achieved
by the determination (via database search) of the unique peptide(s) derived from this protein
(135). The C. albicans protein sequence database (available from
http://www.candidagenome.org/) facilitates the identification of C. albicans proteins via database
search.

The advancement of MS techniques and availability of the full genome sequence of C. albicans
seem to make it theoretically straightforward to catalogue cell wall proteins of the fungus.
However, little progress has been made. Part of the reason is that the heterogeneity of the cell
wall proteins (covalently linked to cell wall) makes sample preparation a formidable task.
Complicated sequential fractionation is required to isolate those proteins from the
polysaccharides network under various chemical and/or enzymatic treatments either from intact
cells (4, 16, 79, 89, 123) or cell wall pellet after cell lyses (70, 110, 132) (40, 71, 98). The
fractionated CWPs were further separated by two-dimensional gel electrophoresis (2D-PAGE)
before LC-MS analysis. This fractionation based sample preparation method may provide some
additional information about how CWPs are linked to the network of polysaccharides.
Unfortunately, the detection of the identical wall proteins in different fractions adds ambiguity in
protein localization. Also, this conventional approach has several limitations: First, the cell wall
fractions collected after cell lyses were subject to potential cytosolic contamination, even after
extensive washing by NaCl solution of various concentrations. While some researchers (132) had
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shown that cytosolic components released from cell lyses didn’t interact with cell wall fractions
in their approach, others reported that the possibility of cytosolic contamination in the cell wall
fractions could not be unequivocally ruled out (41) (94). Second, fractionating steps are time
consuming. Moreover, the extraction process is often incomplete and strain dependent (73).
Third, 2D-gel electrophoresis may not resolve glycoproteins extracted from yeast cell walls
(142) because the same protein may have different glycoforms with different isoelectric points
(51) and molecular weights (144), which may complicate the comparative gel based quantitative
analysis of CWPs because of their multiple locations in the gel.

1.7 Biotinylation technique for cell surface proteome determination
Labeling intact fungal cells by membrane impermeable biotinylating reagents is an attractive
approach toward minimizing the influence of cytosolic contamination. The advantage of this
method is that the biotin reagents react only with cell wall proteins (or their carbohydrate
moiety) on or proteins adjacent to the cell surface. The labeling strategies and reagents share
these common features including: 1. the biotin tag for affinity chromatography; 2. chemical
groups reactive with proteins at lysine (K) or cysteine (C) residues or carbohydrate moieties of
glycoproteins; 3. a spacer of variable length that links the biotin moiety to the protein. The strong
affinity between avidin and biotin was first recognized in 1941 (55), but it was not until 1990
when a biotin-avidin affinity based purification technique was introduced by Wilchek (137).
Due to the very low dissociation constant (Kd ≈10-15 ) of the biotin-avidin complex (136), the
captured biotinylate proteins are stable and released from avidin affinity column only under
harsh elution conditions such as 8 M guanidine HCl. The recovery of sample is therefore often
incomplete (117) and irreversible protein damage may occur during the elution process. This
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problem may be partly solved either by choosing modified avidins with lower affinity such as
nitrated avidin derivatives (96), CaptAvidin (97) and monomeric avidin (61) or using cleavable
biotinylating reagents (e.g. Sulfo-NHS-SS-Biotin, Pierce, Rockford, IL) which allows the
dissociation of labeled protein from the biotin-avidin complex through chemical cleavage of the
linker (e.g. disulfide bond). The lower affinity avidins increase the recovery of biotinylated
molecules as a result of reduced biotin-avidin binding strength, but they are also less tolerant to
detergents, which are necessary in solubilization of membrane proteins co-precipitated with the
cell walls. A disulfide bond linker may also be problematic because it could be susceptible to
endogenous reduction prior to affinity purification (11). In order to increase the efficiency of
binding between large biotinylated biomolecules and immobilized avidin, efforts were made to
incorporate a long spacer into the labeling reagents, which would reduce the steric hindrance
imposed by the bulky biomolecule and facilitate the docking of the biotin moiety into the avidin
binding pocket. The most popular spacer available on the market is a monodisperse PEG
(polyethylene glycol) based linker, which not only allows the efficient capture of the labeled
molecule, but also prevents the aggregation of labeled protein due to the hydrophilic nature of
the linker. It should be noted that mono-PEG spacers have an advantage over their aliphatic
counterparts because of their lower immunogenicity in vivo (59).
The most important part of the labeling reagent is the protein/peptide reactive moiety that
enables biotin conjugation to proteins. An active N-hydroxysuccinimidyl (NHS) ester is the most
commonly used functional group to modify free amine groups in proteins/peptides at pH 7.5-8.5.
Sulfo-NHS ester is water soluble and its biotin derivatives are widely used in labeling cell
surface proteins in vivo due to membrane impermeability of the labeling reagents (negative
charged sulfonate group on NHS ring prevents the penetration of sulfo-NHS-esters of biotin
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through the plasma membrane). Other important functional groups that target cysteine residues
are malemide and iodoacetyl moieties, which react with the free sulfhydryl group in cysteine
residue at pH 6.5-7.5 and 7.5-8.5 respectively. It is noteworthy that the pH of the labeling
reaction mixture needs be strictly controlled to minimize side reactions such as transformation of
malemide by primary amines at pH above 7.5 and iodoacetyl by imidazoles at pH 5.0-7.0.

Sulfosuccinimidyl-6-(biotinamido)hexanoate (sulfo-NHS-LC-biotin) and sulfosuccinimidyl-2(biotinamido)ethyl-1,3-dithiolpropionate (sulfo-NHS-SS-biotin) (see Figure 1.3. for their
structures) are the most commonly used protein biotinylating reagents that react with free amines
from the side chain of lysine residues or N-termini of proteins/peptides, and these labeling
reagents have recently gained much popularity in studying membrane subproteome of
mammalian cells (22, 105, 108, 119, 122, 131), cell surface proteome of bacteria (118) (113)
and fungi species (38, 46, 116). In the field of C. abicans research, investigators have also
benefited from this technique as well as the advancement in mass spectrometry instrumentation
(4, 16) (132) (68) (89). For example, Urban and co-workers (132) employed sulfo-NHS-biotin
labeling technique to monitor the expression of Tsa1p protein in different cell localizations. As
mentioned earlier, the biotinylation labeling reagents are membrane impermeable due to the
sulfonate group in sulfo-NHS-biotin molecule(125). Thus it is surprising that classic cytosolic
and nuclear proteins were also found in of sulfo-NHS-biotin labeled protein fractions (103, 104).
Although it is possible that the labeling reagent may penetrates the membranes through certain
ion channels (e.g Na+) (143) or enters freely into the aging or dead cells whose membrane
integrity has been damaged, it is more likely that the cytosolic and nuclear proteins were nonspecifically bound to avidin during biotin-avidin based affinity chromatography (94).

16

O
+

-

Na O

O

S

O

O

O

N

O

S

A

O

H
N

H

N
H

O
NH

H

O
+

-

Na O

H

O

S

S
O
N

O

S
O

H
N

S

H
O

O

NH

N
H

O

B

Figure 1.3. Structures of sulfosuccinimidyl-6-(biotinamido)hexanoate (sulfo-NHS-LC-biotin)
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Fortunately, such problem can be addressed by coupling the surface labeling technique with
tandem mass spectrometry-based proteomic tools to determine the biotinylation site(s) of
proteins.

1.8 Study on dynamic change of cell surface proteome of C. albicans during the
morphogenesis
Conversion from the yeast form to the hyphal form has become generally recognized as a key
virulence factor when C. albicans cells attack host cells either through epithelium invasion or
endothelium barrier breaching (29) (82). Compared to the CWP profile of C. albicans, the
expression change of CWPs during morphogenesis is largely unexplored. Only a few reports (37)
(110) related to systematic comparison of cell wall proteomes of yeast and hyphal forms were
reported. Recently, Gil and co-workers (91) conducted a comparative proteomic analysis on the
yeast, hyphae and biofims of C. albicans. 2D-gel based approaches were employed in those
studies but yielded limited information due to drawbacks in 2D-gel based quantification (e.g. low
reproducibility and inaccurate measurement of gel spot volume). A two-dimentional differential
in-gel electrophoresis (2D-DIGE ) technique (1) could be employed to improve the
quantification of gel spot, but such approach still has the limitations inherited by all 2D-gel/MS
based quantitative proteomic methods as discussed above(109).

Stable isotopic labeling techniques, especially ICAT® (54), iTRAQ® (114), and SILAC (107)
methods gained considerable popularity and were recently reviewed (23, 49, 102, 120). These
labeling techniques involve both in vitro labeling via attaching isotopic tags to cysteine residues
in protein (ICAT®) or to free amino group in peptide (iTRAQ®) through chemical reactions,
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and in vivo metabolic incorporation of stable isotopes into the proteins expressed by cells
cultured in media supplemented by different isotopes (SILAC). Relative quantification is
achieved by comparative analysis of ion intensities of peptide isotope pairs in the mass spectrum
(ICAT®, SILAC) or by measuring the intensities of report ions derived from the labeled peptides
in the tandem mass spectrum (iTRAQ®). The stable isotope labeling technology offers accurate
quantification of protein accumulation levels from various sources with good reproducibility. A
C. albicans lysine auxotrophic mutant was generated (10) that, when used along the SILAC
technique, will allow us to monitor the CWP accumulation level changes during a yeast to hypae
transformation of this pathogenic fungus.

1.9 Development of “fluorous” affinity tag based labeling reagents
Although biotin-avidin affinity based approaches are widely employed in the
enrichment/separation of biological molecules, several limitations have to be considered when
commercially available biotinylating reagents are employed to label proteins/peptides(50): 1.
Some unlabeled proteins/peptides may nonspecifically bind to avidin (94), resulting in false
identification; 2. The recovery of the biotinylated molecules is often low (26) (126) because of
the high stability of biotin-avidin complex (136); 3. The biotin moiety tends to average the
overall hydrophobicity of the tagged-peptides and compromise the separation of these peptides
on reverse-phase liquid chromatography column(85); 4. Fragments originated from the biotin
moiety can complicate the mass spectral interpretation of biotinylated peptides (106). 5. Biotin
moiety may be cleaved under biotinidase catalyzed enzymatic reactions or through other even
nonenzymatic mechanisms in vivo (12, 13). All these limitations call for the development of new
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labeling reagents with non-biotin affinity tags for enrichment/separation of biological molecules
including proteins/peptides.

The strong non-covalent interaction between fluorinated alkyl group (fluorine-fluorine
interactions) makes the fluorous tag one of the alternative approach to biotin labeling. (27) The
term “fluorous” was initially coined in 1990s to denote molecules with high content of fluorine
atoms (perfluorinated species). The perfluorinated moiety enables fluorous organic compounds
(molecules attached by perfluorinated alkyl chain, like C8F17) to be separated from non-fluorous
compounds by fluorous-functionalized silica gel through solid phase extraction. Non-fluorous
compounds are first washed away by an anti-fluorous isocratic solvent, such as 60% methanol in
water. While the affinity between fluorous moieties is strong enough to allow fluorous molecules
to be retained on immobilized fluorous carriers after the washing, the fluorous interaction can be
disrupted under very mild conditions. Fluorphilic solvents such as methanol and acetonitrile may
serve to elute the fluorous fraction. Interestingly, fluorous compounds can be further fractionated
based on the different number of fluorous tags attached to a molecule by tuning the
fluorophilicity of the elution solvent. Molecules with higher fluorine content would be eluted
later with more fluorophilic solvent (14) (28).

The fluorous affinity technique was first introduced in fluorous biphasic catalysis technique (65)
and soon utilized in a wide spectrum of organic syntheses (145). Recently, its application in
enriching tagged peptides from highly complex biological mixtures was also demonstrated (14).
The technique started to gain popularity in metabolomics (53), and microarrays for immobilizing
small-biomolecules (101, 111).
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CHAPTER 2
Rapid Identification of Yeast Species and Differentiation of C. albicans Strains
by Mass Signatures Acquired by Matrix-assisted Laser Desorption/Ionization
Time of Flight Mass Spectrometry (MALDI-TOF-MS)

2.1 Abstract
Matrix-assisted laser desorption/ionization time of flight mass spectrometry (MALDI-TOF-MS)
was used for rapid identification of yeasts, including strains of Candida albicans. Intact yeasts
were collected from surface colonies on agar-based media, washed in deionized water followed
by 50% methanol, suspended in deionized water to a concentration of approximately 106 cells/ µl
and 1 µl of each suspension was deposited into a well of a MALDI target plate. Among several
matrix compounds investigated, sinapinic acid crystallization worked especially well. Under
these conditions, a sufficient number of medium size ions (4 to 15 kDa) were detectable in the
MALDI mass spectra that could serve as “mass signatures” for unambiguous identification of the
various yeast species and even among strains of C. albicans. Resulting mass signatures were
influenced by many factors, including growth medium, length of incubation and cell preparation.
Under conditions that were optimized for the greatest number of ions with highest intensities, C.
albicans was distinguishable from other Candida species (C. lusitaniae, C. dubliniensis,
C.glabrata, C. rusei, C. kefyr) and from other yeast genera (Cryptococcus neoformans ,
Saccharomyces cerevisiae and a Rhodotorula sp.). Within the species C. albicans species,
several medium sized ions in the 5 to 10 kDa range appeared on the mass spectra of all the
investigated strains. In addition to those shared ions, the mass spectrum of individual strains
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contained unique ions that could be used to distinguish strains of this species. Finally, C.
albicans germ tubes produced MALDI-TOF MS signatures that differed from yeast forms of this
species. This is a simple, rapid and sensitive method of identifying yeasts. Identification of
fungal molecules yielding signature mass spectra is under investigation.

Keywords
Mass signature, MALDI-TOF mass spectrometry, Alcohol fixation, Yeast differentiation,
Principal component analysis
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2.2 Introduction
Several Candida species, and most especially C. albicans, are opportunistic pathogens that are
among the most common causes of fungal infections. Since the advent and widespread use of the
azole (such as fluconazole) group of antifungals which are especially inhibitory for C. albicans,
other Candida spp. resistant to these drugs have emerged with greater frequency, notably like
Candida glabrata (13). Although C. albicans remains the cause of the majority of cases of
disseminated candidiasis, and with resulting high mortality rates, the increase in occurrence due
to several other Candida spp. and their tendency for resistance against standard antifungal drugs,
necessitates identification to the species level. Moreover other yeast genera are also important
etiologic agents of disease and some are common contaminants in clinical and research
laboratories (9, 20, 36, 39). Rapid identification of yeasts to the species level for clinical
purposes, distinguishing strains within a given species for epidemiological investigations and for
strain verification purposes in clinical and research laboratories, and monitoring yeast surface
development in pathogenesis studies are compelling demands that continuously drive technical
advances in the field. There are a plethora of rapid identification methods, ranging from speciesspecific chromophore development on specialized media to molecular genetic approaches (37).
Some of the methods are simple and especially applicable to the presumptive identification of C.
albicans from other yeasts, whereas others provide at least rapid presumptive identification of
most species and can even distinguish strains of a given species, but may be either time
consuming and/or require considerable expertise. The approach of peptide nucleic acidfluorescence in situ hybridization (PNA-FISH) shows potential for rapid identification of yeast
directly in clinical specimens (42). A notable advantage of the PNA FISH is rapid determination
since prior culturing of the etiologic agent is not required. Despite this impressive development
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and other approaches cited above, a single method has not been described that is capable of
handling all of the above applications, including strain grouping and monitoring developmentally
expressed fungal surface characteristics.

Spectroscopic approaches such as pyrolysis-mass spectrometry (Py-MS), Fourier transforminfrared (FT-IR) spectroscopy (45), nuclear magnetic resonance (NMR) (21, 22), and Raman
spectroscopy (25, 32) have been used for Candida species differentiation, but with mixed results
and significant limitations. Either the spectra showed few qualitative differences between species
(45), or the methods and analyses were too complex for practical application (46) (21, 33). In
addition, none have shown utility for either strain grouping or for detection of developmental cell
surface moieties.

Matrix-assisted laser-desorption/ionization time-of-flight mass spectrometry (MALDI-TOF MS)
is an emerging tool for microbe characterization and differentiation at the species and strain
levels (12). Identification of microbes by MALDI-TOF MS requires a relatively small number of
intact cells (106 -107) along with simple sample preparation procedures. Rapid data acquisition
(in seconds) by MALDI-TOF MS and the high specificity of mass spectrometric analysis relative
to the above mentioned techniques allows fast and accurate identification under well-defined
conditions. Early reports focused on rapid identification of intact whole bacteria (23, 28), since
bacteria naturally yield abundant mass spectral signals under standard conditions. These studies
were followed by MALDI-MS identification of toxigenic and pathogenic bacteria (10) (15, 19)
(29, 31, 34) (41) (48, 51, 52), factors affecting spectral quality and reproducibility were defined
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(24, 51), and automated MALDI mass spectra comparison programs were developed to facilitate
rapid identification and speciation of intact bacteria.

Studies of fungal species by MALDI-TOF mass spectrometry (1) (8, 26) (30, 47) are more
recent, but unlike simple preparation of bacteria for analysis, investigators report the need for
multiple sample preparation steps, such as cell wall lysis (1) in order to increase the intensities of
diagnostic signals for species differentiation. Thus, fungi do appear to produce characteristic
MALDI-MS signals, but the signals may be more difficult to obtain as compared to those of
bacteria. Our first aim in this study was to optimize the MALDI-TOF MS analysis of intact yeast
cells and then show the potential application of this technique toward identifying yeast species,
grouping strains within a species, following developmental cell surface changes. Mathematical
analysis of mass spectra from intact cells was also applied, which should be a useful first step in
the development of an automated yeast identification system.

2.3 Materials and Methods
2.3.1 Yeast strains
C. albicans strain 3153A (serotype A) was obtained from the American Type Culture Collection
(ATCC 28367). Strain A9 (serotype B) was originally isolated from the oral cavity of an AIDS
patient (50) and has been used extensively in mouse-C. albicans interaction studies in our
laboratory (16, 38). Strain 6284 (or YJB 6284) was the result of repairing strain BWP17 to
prototrophy (5); it has all the characteristics of a typical C. albicans, including virulence and the
ability to germinate, thus, for the purposes of these studies, it is considered as a wild-type strain.
Strain GPH1 is a vacuolar mutant (vps11∆) derived from YJB6284 (35). The 6284 and GPH1
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strains were gracious gifts from Dr. G. Palmer (Louisiana State University Health Sciences
Center, New Orleans). Other yeasts in this study included C. albicans ATCC 60193, C. glabrata
(ATCC 15126), C. krusei (ATCC 6258), C. kefyr (ATCC 8553), Cryptococcus neoformans
(ATCC 32045 and ATCC 66031), and Saccharomyces cerevisiae (ATCC 9763 and ATCC
24903). In addition, strains of Rhodotorula spp. (y2.929 and y2.196) and Candida dubliniensis
were graciously provided by Dr. K.C. Hazen (University of Virginia Health Sciences Center,
Charlottesville, VR).

2.3.2 Culture conditions
Unless otherwise specified, the surveyed yeast cells were stored as water stocks, and cultured on
an agar medium containing YNB (yeast nitrogen base) (Becton, Dickinson and Company)
supplemented with 2% glucose in Petri dishes at 22-23˚C for 4 days. In some cases, yeast cells
were grown at 37˚C for two days or at 22-23˚C for 4 days on glucose (2%)-yeast extract (0.3%)peptone (1%) agar (GYEP agar). After incubation, isolated colonies were picked to make fresh
water suspensions for MALDI-TOF mass spectrometry analysis.

The yeast form of C. albicans strain 6284 was induced to germinate (or produce hyphae) by
nutritional and temperature shifts. After growth on GYEP agar plates at 22-23ºC for 4 days, the
yeast cells were carefully removed, washed twice in sterile deioinized water, and inoculated at 2
x 106 yeast forms/mL in DMEM (Dulbecco’s Modified Eagle’s Medium HEPES Modification,
Sigma) with 2.5% fetal bovine serum followed by incubation at 37 ˚C for 2 h or for 4 h under
aeration by rotation at 180 rpm. Under these conditions, over 95% of the yeast cells germinated
to become hyphal elements as determined microscopically by the formation of elongated
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structures without evidence of constrictions at the point of emergence from the mother cell. The
germ tubes were washed in deionized water at least twice before further treatment.

2.3.3 Methanol (alcohol) fixation of fungi.
Unless otherwise specified, the washed yeast cells were fixed by suspension in 50%
methanol/water (v/v) (EMD Chemicals, San Diego, CA) and either analyzed immediately or
stored at 4-6°C for up to 45 days for subsequent comparison analysis. The germ tubes were
subjected to the same wash and fixation steps as the yeast cells. In some cases, the fungal cells
were fixed in 80% or 100% methanol, and in 50% or 100% isopropanol (Sigma, St Louis, MO)
using the same approach as above.

2.3.4 Matrix/sample spotting method.
Each alcohol-fixed preparation of yeast cells was suspended by vortexing and 0.5 µl of each was
immediately transferred to wells of a 100-well gold-coated MALDI target plate (Applied
Biosystems). Each well was immediately overlaid with 0.5 µl matrix solution. The samplematrix mixtures were allowed to dry at room temperature in ambient air for about 20 min. All
sample suspensions were deposited in duplicate on the MALDI target plate. A two-layer method
of sample preparation (49, 53{Vorm, 1994 #181), which entailed drying the sample before
covering it by the matrix solution, was also tested, but it provided no advantage over the
previously described dried-droplet method (27) (data not shown). Three commonly used matrices
were compared: α-cyano-4-hydroxycinnamic acid (CHCA, Fluka), sinapinic acid (SA, Fluka)
and 2,5-dihydroxybenzoic acid (DHB, Fluka). Each was freshly prepared as a saturated solution
in 2:1 acetonitrile (EMD Chemicals) : water containing 0.1% trifluoroacetic acid (TFA, Sigma).
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2.3.5 MALDI-TOF mass spectra acquisition
Mass spectra were acquired on a Voyager-Elite MALDI rTOF mass spectrometer (Applied
Biosystems, Framingham, MA) operated in the positive ion linear mode. The intensity of the
nitrogen laser (at 337 nm) was set significantly above the threshold for desorption/ionization
(between 2000 and 2400). The accelerating voltage was 25 kV with an extraction delay time of
250 ns. For each sample spot (approximately 5 mm in diameter on the MALDI target plate), an
average of 75 laser pulses were delivered at one point, and the final spectrum was the
accumulation/average results obtained from at least 5 different points on a given same sample
spot. Due to performance limitations of the linear mode of the MALDI-TOF mass spectrometer,
mass assignments of ions with a mass to charge ratio (m/z) larger than 5,000 Daltons (Da) may
bear an error of 10-20 Da. Cytochrome C (12,362 Da), myoglobin (16,700 Da) and ubiquitin
(8,565 Da) (Sigma, St. Louis, MO) were used as standards for external calibration.

2.3.6 Principal component analysis (PCA)
MALDI mass spectra of intact yeast cells were calibrated and processed using “Data Explorer”
(Applied Biosystems). Some of the mass spectra were evaluated by PCA (17, 18). After the
spectrum baseline was corrected to zero, up to 25 of the most abundant ions in the range of m/z
4000 – 15,000 were first selected. Among the possible 25 peaks, those with a relative intensity
less than 5% and those with a signal/noise ratio less than 3 were discarded. The most intense
peaks from each mass spectrum were compiled into a peak list with no redundancy. Each mass
spectrum was compared with the compiled peak list to generate a data matrix in which the
matched peaks (relative intensity higher than 5%, S/N larger than 3 and no more than 25 peaks)
were denoted as 1 (100%) and the rest of the unmatched peaks were denoted as zero. PCA was
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performed on the data matrix by using the MatLab program (The Math Works, Inc. version 7.0).
Plotting of each spectrum was limited to the first and second principal component scores, PC1
and PC2, respectively.

2.4 Results
2.4.1 Concentration of yeast cell suspension
C. albicans 6284 was used as the prototypic strain to evaluate the influence of yeast cell
concentration on the quality of mass spectra. In preliminary experiments, water-washed yeast
cells mixed directly with the matrix sinapinic acid (SA) matrix provided evidence that
approximately 0.5x106 yeast cells/0.5µl was optimal for MALDI mass spectral analysis. Fewer
satisfactory mass spectral peaks were observed at both higher and lower cell concentrations (data
not shown).

2.4.2 Effect of alcohol fixation
Fixing the yeast cells in 50% methanol was initially employed as a killing step, but it
surprisingly led to a significant increase in the number of ions in the MALDI mass spectrum. For
instance, non-methanol-treated C. albicans A9 yielded only two significant peaks between m/z
3000 and 15000 (Figure 2.1a) as compared to a large number of peaks (more than ten) following
methanol fixation (Figure 2.1b). Fixation treatments of 80% or 100% methanol or isopropanol
(50% and 100%) offered no advantage over the 50% methanol fixation. Fixation had the
additional advantage of minimizing yeast cell aggregation and, therefore, more reproducible cell
number transfer to the target plate, as compared to the tendency for increased aggregation of
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some strains suspended in water alone. For the remainder of this study, 50% methanol fixation
was used unless otherwise specified.

2.4.3 MALDI matrix selection
MALDI analyses of C. glabrata ATCC 15126 and C. albicans A9 produced different spectral
qualities depending on the choice of matrix (Figure 2.2). When DHB was employed as the
matrix, both C. glabrata ATCC 15126 (Figure 2.2a) and C. albicans A9 (Figure 2.2d) yielded
poor quality mass spectra with only a few significant signals in the high mass range (m/z 5000 –
15,000). Matrix CHCA (Figure 2.2b and 2e) worked somewhat better than DHB, but not as well
as SA (Figure 2.2c, and 2f). SA was chosen as the most suitable matrix because it produced the
most peaks with acceptable signal/noise ratios, and it promoted signal generation in the highmass range.

2.4.4 Effect of incubation conditions on C. albicans mass spectra
Examination of four C. albicans strains grown on GYEP medium under the two conditions of
37 °C for 2 days and 22-23 °C for 4 days showed that the influence of incubation conditions on
MALDI mass spectra of intact yeast cells was strain dependent. For example, the mass spectra
of C. albicans strain A9 under the two growth conditions (Figure 2.3a and 3b) did not change
dramatically as noted by the presence of high abundant ions on both spectra, such as m/z at
5217, 5910, 6207, 6904, 8552, and 9762. As for C. albicans 3153A, however, significant
changes could be observed when comparing the MALDI spectra acquired under the two
conditions (Figure 2.3c, at 22-23 °C for 4 days, and Figure 2.3d, at 37°C for 2 days). Some ions
in the high mass range (m/z at 11341, 12279 and 13161) were evident from cells grown at 37ºC,
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Figure 2.1. Alcohol fixation improves the quality of the MALDI mass spectrum. Candida
albicans A9 yeast cells were prepared by either washing in deionized water (a), or washing in
deionizied water followed by fixation in 50% methanol:water (b). Sinapinic acid was employed
as the MALDI matrix and the concentration of the yeast cell suspensions was 106 cells/µL.
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Figure 2.2. Three commonly used matrix compounds: 2,5-dihydroxybenzoic acid (DHB), αcyano-4-hydroxycinnamic acid (CHCA) and sinapinic acid (SA) were compared. MALDI
spectra of C. glabrata ATCC 15126 were acquired in the presence of DHB (a), CHCA (b) and
SA (c). In parallel and under the same conditions, MALDI mass spectra of C. albicans A9 were
acquired in the presence of DHB (d), CHCA (e), and SA (f). When SA was employed as the
matrix, MALDI-MS produced more useful mass signatures for both C. glabrata ATCC 15126
(c) and C. albicans A9 (f). SA was selected as the optimal matrix in the mass signature
acquisitions of all other yeast species and strains in this study.
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but not 22-23ºC. C. albicans strains GPH1 and 6284 also showed similar patterns of mass
spectral changes when the spectra (not shown) of the same strain grown at the two temperatures
and durations were compared.

2.4.5 Characteristic mass spectral ions generated from C. albicans.
The four C. albicans strains grown at 22-23˚C on GYEP agar for 4 days provided highly
reproducible mass spectra, not only for the same strain tested at different locations on the target
plate, but also for replicates the same strain grown under the same conditions on different days.
Mass spectral comparisons showed a high degree of similarity between strains 3153A (Figure
2.3a) and A9 (Figure 2.3b), and both closely matched strain 6284 (Figure 2.3e). Mutant strain
GPH1 however, showed significant differences from the other strains (Figure 2.3f), ions in the
range of m/z 7000 – 8000 and above 11,000 were
apparently not shared by the other three strains. Eight common ions at m/z 5110, 5217, 5785,
5910, 6207, 6904, 8552 and 9762 appeared on the spectra of all four strains, which provided
evidence that these signals might serve as signature markers for C. albicans under the employed
conditions.

2.4.6 PCA analysis of C. albicans mass spectra.
PCA analysis was performed on the spectra of the four C. albicans strains grown under identical
conditions except that the length and the temperature of growth were varied for comparison
purposes. C. albicans strain 3153A incubated under two different conditions (at 22-23 °C for 4
days and at 37 °C for 2 days) showed variation in the mass signatures (Figure 2.3c and 3d),
which became more obvious by PCA analysis (Figure 2.4, the solid and hollow rectangle
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symbols, respectively). The mass signatures of C. albicans strain 6284 grown under the two
growth conditions also had noticeable differences (Figure 2.4, the solid and hollow triangle
symbols). The mass signature of C. albicans GPH1 (Figure 2.3f) was quite different from those
of C. albicans strains A9 (Figure 2.3a), 3153A (Figure 2.3b), and 6284 (Figure 2.3e). PCA
analysis of these mass signatures indicated that GPH1 (the hollow circle in Figure 2.4) can be
distinguished from the other three strains (the hollow rectangle, triangle and plus symbol in
Figure 2.4) based on the first principle component (the x-axis in Figure 2.4). Similar mass
signatures were grouped together on the PCA plot (Figure 2.4). GPH1 incubated under two
conditions formed one group, whereas the other three strains (3153A, A9 and 6284) grown 2223 °C for 4 days formed another cluster. The latter cluster (around coordinates -1, 0 in Figure
2.4) also included the spots (small # and + symbols that represented the mass signatures of
strains 3153A and A9 incubated at 22-23 °C for 4 days followed by fixation in 50% methanol
and storage at 4 °C for 45 days before mass spectrometry analysis). Storage at 4 °C for 45 days
after fixation in 50% methanol appeared to have little effect on the mass signatures of C.
albicans 3153A and A9. These data demonstrate that the mass signature of the same strain is
reproducible and stable even upon relatively long-term storage.

2.4.7 Differentiation of yeast species.
A mass spectral survey on strains of various Candida species cultured on YNB-glucose agar
medium at 22-23 ˚C for 4 days indicated that each species could be distinguished (Figure 2.5).
The three non-Candida yeasts, C. neoformans, Rhodotorula sp. and S. cerevisiae also produced
distinct mass spectral signatures that were distinguishable from the Candida species and from
each other (Figure 2.6). C. neoformans produced ions evident at m/z 5736, 6722, 8539, 8539,
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Figure 2.3. MALDI mass spectra were acquired for the four C. albicans strains grown on GYEP
agar medium. Effect of growth conditions on the MALDI mass spectra is strain dependent.
Similar MALDI mass spectra were acquired for C. albicans A9 grown at 22-23ºC for 4 days (a)
and 37ºC for 2 days (b). Differences, especially in the high mass range, are quite obvious when
comparing the mass spectra of C. albicans 3153A grown at 22-23ºC for 4 days (c) and grown at
37ºC for 2 days (d). Under constant growth conditions at 22-23ºC for 4 days C. albicans strain
GPH1 (f) could be distinguished by its MALDI mass signature from (a) C. albicans A9, (c) C.
albicans 3153A, and (e) C. albicans 6284.
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Figure 2.4. Principal component analysis (PCA) of the mass signatures of C. albicans strains
A9, 3153A, 6284, and GPH1. Each spot on the plot represents a mass spectrum. For each mass
spectrum used in the PCA analysis, no more than 25 peaks with relative intensity higher than
5%, S/N larger than 3 were denoted as 1 (100%) and the rest of the peaks were denoted as zero.
PCA analysis reduced the multi-dimensional features (i.e., mass peaks denoted as 1) of each
signature spectrum down to two principal components (PC1 and PC2). Hollow symbols: cells
cultured at 22-23ºC for 4 days; solid symbols: cells cultured at 37ºC for 2 days. All strains were
cultured on GYEP agar medium. The small cluster on the right includes the mass signatures of C.
albicans GPH1 grown under two different conditions:
represents the mass spectrum of
Figure 3f. The large cluster on the left includes the mass signatures:
(spectrum see Figure 3a);

C. albicans A9

C. albicans 3153A (spectrum see Figure 3c):

C. albicans A9

(spectrum see Figure 3b);
C. albicans 6284 (spectrum see Figure 3e); # (C. albicans
3153A) and + (C. albicans A9): cell cultured at 22-23ºC for 4 days, treated by 50% methanol
and stored at 4ºC for 45 days before MALDI analysis.
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8640 and 9405, all of which are shared by the two strains of this species (Figure 2.6a and 6b).
The two strains of S. cerevisiae shared ions at m/z: 4053, 4681, 4752 and 5500 (Figure 2.6c and
6d). Compared to other species in the survey, the two Rhodotorula sp. strains produced fewer
peaks in their spectra (Figure 2.6e and 6f), with two shared ions at m/z 4501 and 8536. For all
the MALDI-MS profiled yeast strains, no two strains within a given species produced identical
spectra, and the mass spectral differences between different species were even more evident.

PCA analysis of the mass signatures of C. albicans ATCC60193, C. kefyr (ATCC 8553), and C.
neoformans (ATCC 32045 and ATCC 66031) showed that these species could be clearly
distinguished on a PCA plot (Figure 2.7). Different strains within the same species, such as C.
neoformans ATCC 32045 (Figure 2.6a) and ATCC 66031(Figure 2.6b), could also be
distinguished by their mass signatures, however, usually there were fewer differences in mass
signatures between strains within a species as compared to differences between species.
Examples of mass signature reproducibility are offered by the close proximity of the two C.
glabrata ATCC 15126 spots and the three spots of C. albicans ATCC 60193 on the PCA plot
(Figure 2.7). The two mass signatures of C. glabrata ATCC 15126 were from replicate analyses
of the same sample, while the three mass signatures of C. albicans ATCC 60193 were from three
independent colonies. These data along with stability and reproducibility of spectra shown in the
previous section provide evidence that MALDI-TOF mass spectral analyses are predictable
under prescribed conditions of growth and sample preparation.
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Figure 2.5. The MALDI mass signatures distinguish different species of Candida. When
cultured under the same conditions (YNB with 2% glucose media at 22-23ºC for 4 days), C.
dubliniensis (a), C. albicans ATCC 60193 (b), C. glabrata ATCC 15126 (c), C. krusei ATCC
6258 (d) and C. kefyr ATCC 8553(e) could be distinguished by their mass signatures.
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Figure 2.6. MALDI mass spectra can be used to differentiate between different fungal genera
and strains within each genus. When grown under conditions similar to those used for data
obtained in Figure 5, unique mass spectra were obtained from Cryptococcus neoformans strains
ATCC 32045 (a) and ATCC 66031 (b), Saccharomyces cerevisice strains ATCC 9763 (c) and
ATCC 24903 (d), Rhodotorula sp. strains y 2.929 (e) and y 2.196 (f).
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Figure 2.7. The reproducibility of mass signatures was confirmed by PCA analysis. Acquired
under identical conditions, the mass spectra (three circles) of C. albicans ATCC 60193 sampled
from 3 different colonies on the same Petri dish were similar; nearly identical mass spectra (two
diamonds) were also acquired for the same C. kefyr ATCC 8553 sample spotted on different
locations of a MALDI target plate. It should also be noted that the mass spectral differences
between yeast species (C. albicans ATCC 60193, C. kefyr ATCC 8553 and Cryptococcus
neoformans) were greater than the mass spectral differences between strains (ATCC 32045 and
ATCC 66031) of the same species (Cryptococcus neoformans).
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2.4.8 Comparison of yeast and hyphal (germ tubes) forms of C. albicans
The MALDI mass spectrum of C. albicans strain 6284 yeast forms (Figure 2.8a) was compared
to that of the same strain germinated for 2 h (Figure 2.8b) and for 4 h (Figure 2.8c). The
surprising finding was that the spectrum of the 4 h germination sample was rather similar to that
of the yeast form, whereas the spectrum obtained from germination at 2 h differed significantly.
More ions, especially in the high mass region, were generated by the 2 h germination sample
during the MALDI process. A possible explanation is that at 4 h almost all germ tubes had
aggregated and were difficult to suspend in 50% methanol, which caused variability of sample
delivery to the target plate. To test this possibility, the amount of sample applied to the target
plate was varied, but the high mass ions were consistently absent in the mass spectra (data not
shown). The same experiment was repeated on another germination sample preparation of C.
albicans strain 6284, and the results were consistent. That is, several high mass ions (e.g., above
m/z 7500) appeared on the mass spectra of 2 h germinated sample, but the higher mass ions were
absent on the mass spectra of the 4 h old germ tubes.

2.5 Discussion
The work presented here shows the potential power of the use of MALDI-TOF mass
spectrometry as a rapid means for yeast identification, grouping strains within a species
and for following surface changes during a yeast-to-hyphal transition of C. albicans. Many
parameters (e.g. the concentration of yeast suspension, type of MALDI matrix employed)
were considered during optimization of the experiments as well as data analysis and presentation.
The approach developed in this study should be applicable to all fungi, including molds.
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Figure 2.8. C. albicans strain 6284 was analyzed as yeast forms (a), as 2 h old germ tubes (b),
and as 4 h old germ tubes (c). The mass spectra of yeast form (a) and 4 h old germ tubes (c)
were similar, but the mass spectrum of 2 h old germ tubes (b) differed from (a) and (c).
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In MALDI analyses, sample preparation and selection of an appropriate matrix compound are
essential considerations in protocol development. The tight cell wall construction of fungi
apparently limits intimate contact of the surface components with the MALDI matrix crystals,
which results in low count ion signals and poor quality of mass signatures. Enhancement of
contact of surface fungal molecules with the matrix requires an optimal ratio between the matrix
and fungal molecules (analyte); unbalanced matrix/analyte ratios lead to reduced or even total
supression of analyte signals. Since the volume and concentration of the yeast cell suspension
deposited onto each sample spot of the MALDI target plate was usually constant, the ratio of
matrix:number of intact yeast cell was optimized by varying the concentration of the cell
suspension solution. Analysis of approximately 0.5x106 yeast cells provided the best mass
spectral result for C. albicans 6284 and other fungal cells under the conditions employed in this
study.

2.5.1 Methanol fixation of fungal cells – When analyzed by MALDI mass spectrometry, intact
fungal cells that were washed in water prior to mixing with a matrix solution and spotting did not
produce sufficient diagnostic ions in the range of m/z 4000 to 15,000 (Figure 2.1a), which is in
agreement with a previous report (1). Several sample treatment methods, such as sonication (47)
and boiling (24) (51), increased MALDI-MS signals of bacteria, however, these methods failed
to give satisfactory results in our investigation on yeast cells (unpublished data). Since one group
of investigators obtained improved ionization of medium sized molecules following ethanol
fixation of whole bacterial cells (51), and as a measure of safety in the handling of potentially
infectious organisms, we examined the effects of alcohol fixation on yeast cells. In addition to
improving the mass spectral signals, inclusion of alcohol, such as methanol or isopropanol, in the
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fixation buffer also facilitated suspension of the yeast cells and reproducibility in sample spotting
onto the MALDI target plate. The novel mass spectral signals obtained following alcohol
fixation were also reproducible as discussed below, leading to mass signature assignments.
Compared to the cell wall lysis procedures used by others (43) (1) which may yield a larger
number of mass spectral peaks, the alcohol fixation approach described in our work is more
rapid, simple and it also inactivates potentially hazardous organisms.

2.5.2 Yeast genera and species differentiation by mass signatures – Although the number of
strains was small for each species studies, the results indicate that MALDI mass signatures can
be employed to differentiate yeast cells at the genus level, as is clearly demonstrated in Figure
2.6. The mass spectral differences between C. neoformans (Figure 2.6a and 6b), S. cerevisiae
(Figure 2.6c and 6d), and Rhodotorula sp (Figure 2.6e and 6f) are evident by simple visual
inspection. Differences in mass signatures can also be determined by visual examination for
different species within the genus Candida (e.g. Candida spp in Figure 2.5). The reproducibility
of mass spectra collected under a prescribed set of conditions allows comparisons to be made on
spectra acquired at different times. For example, the mass signatures of Candida spp in Figure
2.5 can be compared with mass signatures shown in Figure 2.6, whereas the mass spectra shown
in Figure 2.3 should not be compared to those displayed in Figure 2.5 and 6 because the yeast
cells used for data shown in Figure 2.3 were cultured under different conditions.
Mass signatures may be useful for the differentiation of strains within a given species, but this is
not always the case. For example, in Figure 2.6 different strains of the same species showed
differences in the mass signatures, and in Figure 2.3 the mass spectrum of C. albicans GPH1
(Figure 2.3f) was quite different from the mass spectra of C. albicans A9 (Figure 2.3a), 3153A
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(Figure 2.3c) and 6284 (Figure 2.3e). The departure of the mutant GPH1 from other wild-type
strains of C. albicans is of interest, because the vacuolar deficiency of GPH1 may well result in
cell wall surface changes which may be reflected in the mass spectral signature for this strain.
Further work is needed to determine the usefulness of mass spectral analysis of yeast mutants.
The mass spectra of C. albicans strains A9, 3153A and 6284 were not sufficiently distinct for
differentiation. The signatures of these strains shared a series of ions, such as m/z 5217, 5910,
6904, 8552 and 9762 (Figure 2.3); these ions can be used to group the three strains. A greater
number of strains need to be surveyed in order to gain a more thorough appreciation of the power
of the mass signatures approach in grouping strains, and possibly mutants, within a given
species.

2.5.3 Reproducibility of mass signatures under well defined conditions - Rapid yeast
identification by MALDI-MS is an attractive approach because of its simplicity and potential for
high throughput analyses. Although the production of diagnostic signals in MALDI mass spectra
is the key to the approach, reproducibility of the signals is critical. In our work, the spectra were
highly reproducible provided that the organisms were grown and fixed under a common set of
conditions. In general, alcohol fixation worked well, but 50% methanol fixation consistently
yielded a sufficient number of diagnostic signals that could be used to constitute a mass signature
for a given species. Other important parameters that could affect mass signature reproducibility
included the number of yeast cells placed in the MALDI sample spot, choice of matrix
compound, sample spotting technique, and cell incubation conditions. For example, yeast cells,
such as C. albicans strain A9, grown at 37 ºC for 2 days (Figure 2.3a) yielded essentially the
same mass signature as when grown at 22-23 ºC for 4 days (Figure 2.3b); but for other yeast
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cells, such for C. albicans strain 3153A, the mass signatures (Figure 2.3c and 3d) varied
somewhat depending on the temperature and length of growth. In the latter example, even though
there were obvious changes in some of the characteristic signals, several diagnostic peaks were
recorded regardless of growth temperature (e.g. m/z 6904, 8552, 9762). For identification and
differentiation purposes, the MALDI mass signatures of yeast cells should be acquired from
fungal cells grown and prepared under the same conditions so as to minimize variations in the
mass signature of a given strain.

Under the same conditions of growth and sample preparation, our findings concerning the
reproducibility of mass signatures is consistent with other results reported on MALDI-TOF
analysis of bacterial cells (2, 40). In addition, we found that fungal cells could be stored prior to
mass analysis without significantly affecting the results. For example, the mass signature
acquired for C. albicans strain A9 incubated at 22-23 ˚C in GYEP for 4 days and immediately
treated with 50% methanol followed promptly by MALDI-TOF mass spectrometry analysis
provided essentially identical signals as when the same strain was grown under identical
conditions except that it was stored for 45 days at 4 ˚C before methanol fixation and mass
analysis. The two mass signatures (spots: + and

in Figure 2.4) can be clustered together as

revealed by PCA analysis. Mass signatures were also consistent for the same yeast strain
deposited on different sample spots on the same MALDI target plate, as well as on different
sample spots on different MALDI target plates (See Figure 2.7, duplicate analysis of C. kefyr
ATCC 8553), and for separate colonies grown in different areas of the same Petri dish (See
Figure 2.7, the three C. albicans ATCC 60193 spots).
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2.5.4 PCA analysis of mass signatures – As indicated above, diagnostic signals are consistent
under a prescribed set of conditions, but the relative peak intensities of a given ion signal may
vary from spectrum to spectrum. To minimize this variability for PCA analysis we degenerated
the relative intensities of diagnostic peaks to zero and 100%, thus leaving the presence of
diagnostic peaks as the only characteristic feature. This simplified approach was effective in
clustering the mass signatures of the same yeast strain, even when the data were acquired from
yeast prepared under slightly different conditions. As shown in Figure 2.4, the spot that
represents the mass signature of C. albicans 3153A grown at 22 ºC for 4 days (

) can be

clustered with the same strain grown under the same conditions but stored for 45 days (#).
Importantly, this PCA analysis approach is an effective tool in clustering intact yeast cell mass
signatures even without prior information, such as the genotype and phenotype of a given yeast
of interest. Thus, PCA employed as a mass signature clustering tool has the potential of playing
an important role in both small and large scale yeast identification.

2.5.5 Origin of the diagnostic signals - Analyte molecules that are in physical contact with the
matrix molecules are those that can be desorbed/ionized leading to their detection and display in
mass spectra. Since the matrix molecules are not capable of penetrating the cell wall, the medium
sized molecules (4000-15000 Da) detected in our work most likely originate from the yeast cell
surface. One possible explanation for the increased signals following alcohol fixation is that cell
surface macromolecules unfold, thus exposing medium size molecules (4000 to 15000 Da) to the
matrix. A second possibility is that the fixation may have promoted release of cell membrane or
cytosolic materials to the cell surface and contact with the matrix. The yeast cell wall
biopolymers are comprised of proteins and polysaccharides (7). Since MALDI-MS ionization
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conditions in the linear mode preserve even weak non-covalent hydrogen bonds (11) (6, 44), it is
unlikely that covalent bonds of the large biopolymers would be cleaved to yield fragments
smaller than 15 kDa. Given the flux and energy of the UV laser employed in our experiments,
we cannot, however, totally rule out the possibility that certain weaker covalently bound cell
surface biopolymers might be cleaved and yield ions in the range of m/z 4000 – 15,000.

Sinapinic acid is a well described MALDI matrix compound that is especially useful for the
analyses of peptides and small proteins (3, 4). In our study, this matrix worked the best among all
those tested for analyses of the intact yeast cells (Figure 2.2), which is consistent with another
report (19), and this suggests that the detected ionized yeast cell surface molecules may well be
proteins/peptides, or molecules with amino acid residues. In addition, in this study we employed
the “dried droplet” method in MALDI sample spotting, which favors ionization of proteins and
peptides (14). The polysaccharides that are abundant on the yeast cell surface would require a
different matrix compound and sample spotting method for efficient ionization (6), (14).

2.5.6 Monitoring the mass signatures of C. albicans at different morphological states - C.
albicans typically undergoes morphogenesis upon tissue invasion, resulting in the formation of
several fungal forms, including yeast (blastospores or blastoconidia) , hyphae (germ tubes or
mycelia) and pseudohyphae. We found that each morphogenetic form of C. albicans (wild type
strain 6284) is characterized by a unique mass signature (Figure 2.8). It should be noted that the
2 h germinated C. albicans (pseudohyphae) yielded the most ions in the range of m/z 4000 –
15,000, which implies that changes in the pseudohyphal cell wall may promote the release of
more mid-size molecules (Figure 8b). The results for the 4 h germ tubes were surprising in that
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they differed from the 2 h germ tubes, and, instead, appeared more like yeast forms. The noted
difficulty in spotting due to aggregation of 4 h germ tubes may have resulted in clumps of
hyphae directed away from contact with the matrix, exposing mostly the mother yeast cells.
Alternatively, by 4 h the hyphal cells may be in transition back to the yeast form. These
explanations are currently under investigation. Regardless of the explanation, unique signals
were obtainable during the transition of yeast to hyphal forms. Identification of these unique
signals is the subject of current studies.

2.6 Concluding remarks
In this study, we demonstrated that the MALDI-TOF mass spectra of intact yeast cells can
provide mass signatures for identification of fungal cells at the genus and species levels. If
appropriately fixed before analysis, intact yeast cells will produce mass signatures just as readily
as those produced by bacteria without prior any treatment. Mass signatures could also be
employed to differentiate strains within a genus, or at least group together yeast strains in case
where difference between individuals was not remarkable. The identification process is rapid,
and requires a tiny amount of sample (106 -107 intact cells). Fixation of the pathogenic yeast with
50% methanol in water greatly improves the quality of the MALDI mass spectra in terms of
increasing the number of characteristic ions with better signal-to-noise ratios. Aided by
mathematical tools such as principal component analysis, the creation of MALDI mass signature
libraries will serve as an effective tool for fast identification of intact yeast cells in clinical and
research laboratories.
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CHAPTER 3

Synthesis and Applications of “Fluorous” (Fluorinated Alkyl) Affinity
Reagents That Label Primary Amine Groups in Proteins/Peptides

3.1 Abstract
Strong non-covalent interactions such as biotin-avidin affinity are commonly utilized in
protein/peptide enrichment/separation. A new type of “fluorous” (fluorinated alkane) affinity
gained popularity due to its low level non-specific binding to proteins/peptides. We developed
two generations of fluorous labeling reagents which were reactive toward primary amine groups
in proteins/peptides. The 2nd generation reagents were highly water soluble and the labeling
reactions with proteins/peptides could proceed in an aqueous environment. The acid labile linker
in the labeling reagent allows cleavage of the bulky fluorous tag moiety and the long oligo
ethylene glycol (OEG) spacer after fluorous affinity purification. Upon collision induced
decomposition, the labeled peptide ion yielded a characteristic fragment that could be retrieved
from the residual portion of fluorous affinity tag, and served as a marker to indicate that the
relevant peptide had been successfully labeled. Analysis of results showed that both the labeling
and affinity enrichment/separation process were highly efficient.
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3.2 Introduction
Proteins and peptides in living organisms accumulate at different levels with wide dynamic
range. It is usually necessary to enrich and/or purify native proteins and peptides for further
characterization. Given the complexity of biological samples, extraction and fractionation of
proteins/peptides of interest can be challenging.
Conjugating an affinity tag to protein/peptide is an attractive approach in protein/peptide
enrichment and purification. Certain functional groups, such as a thiol group from cysteine(7), an
amine group from lysine (20) (12) and a phenol group from tyrosine (10) could serve as direct
targets for conjugation. A few other functional groups from post modifications, such as
phosphoserine and phosphothreonine were suitable to be converted to thiol first, and then
conjugated with an affinity tag (1, 14).Biotin is almost exclusively chosen as the affinity tag
moiety in conjugating reagents due to the biotin-avidin interaction, which is one of the strongest
non-covalent interactions in nature with a dissociation constant (Kd) of 10-15 (21). For affinity
purification purpose, this well-known biotin-avidin interaction also has several limitations: 1.
Some proteins/peptides may nonspecifically bind to avidin (11); 2. Low recovery of the biotintagged molecules in affinity purification is common because of the incomplete elution of
biotinylated molecules from avidin resins (4) (19); 3. The biotin moiety tends to average the
overall hydrophobicity of the tagged-peptides and compromise the separation of these peptides
on reverse-phased liquid chromatography column (9); 4. Fragments originated from biotin
moiety can complicate the mass spectral interpretation of biotin tagged peptides (14).
Incorporation of cleavable linker between the biotin moiety and the peptide reactive group
allows the removal of biotin moiety, and this approach has been employed in cleavable ICAT
reagents (9, 22) that targets the free thiol group in proteins/peptides.

65

The fluorine-fluorine interaction (“fluorous affinity”) based binding and separation was first
demonstrated in fluorous biphasic catalysis technique (8). Since then the fluorous affinity
method has been successfully utilized in a wide spectrum of organic syntheses (23). Recently,
its application was introduced to proteomics (3), metabolomics (6), and microarrays for
immobilizing small-biomolecules (17) (13, 16). The flourous affinity is characterized by the
strong non-covalent interactions between the fluorous affinity tag (which can be conjugated to
molecules of interest) and fluorous resin. The interactions between fluorous resin and
proteins/peptides are generally weak, the non-specific binding of protein/peptides to the fluorous
resin, if any, can be easily disrupted. Moreover, fluorous affinity based separation technique
allows fractionation of the same molecules with different number of fluorous tags (3). Similar
phenomenon can not be found in biotin-avidin based separation approaches.

Unlike the biotin group, which is quite small (244 Da), the fluorous tags are usually quite large
with 448 Da for a commonly used tag C8F17CH2CH3. The strength of fluorous affinity increases
with the number of fluorine in the fluorous tag (5). Moreover, fluorous compounds are general
water insoluble due to the very strong hydrophobicity of fluorous tag. This main caveat limits its
application in biological system where physiological environment need be maintained (e.g. in
PBS buffer) and may cause protein aggregation from multiple “post-modifications” by fluorous
tags. Also, the bulky fluorous affinity tag complicates the fragmentation pattern of tagged
peptides and makes it more difficult to interpret the tandem mass spectra of tagged peptides.
Incorporation of a polar, hydrophilic spacer between the fluorinated alkyl moiety and the reactive
group will increase the solubility of the reagent and labeled protein, however, the fragmentation
pattern of the tagged peptides will be complicated by the fragment ions from the spacer.
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Therefore, it is necessary to remove the fluorous tag and spacer from the labeled molecule before
LC-MS analysis.

In this study, we developed two generations of fluorous reagents (1st generation fluorous labeling
compound: Boc-pentanoic-NHS-perfluoroctane (FBPNHS) (Figure 3.1 A ) and 2nd generation
compounds including two analogues: sulfo-NHS-(OEG)3-perfluoroctane (FP3CMSNHS), sulfoNHS-(OEG)1-perfluoroctane (FP1CMSNHS) (Figure 3.1 B and C) which both could label free
amines from peptides and proteins. Compared to our 1st generation labeling reagent (FBPNHS),
which is not water soluble, the 2nd generation molecules are novel water soluble fluorous
labeling reagents that included a protein/peptide reactive group (Sulfo-N-Hydroxylsuccinimidyl
ester, Sulfo-NHS) (18), an acid labile linker (a tertiary carbomate group), an oligoethylene glycol
(OEG)3 spacer and a perfluorinated alkane moiety (C8F17). Labeling protein/peptides with our
synthesized flourous labeling reagents (A and C in Figure 3.1) was demonstrated along with the
purification/separation and LC-MS analysis of the tagged protein/peptide.

3.3 Materials and Methods
Fluorenylmethoxycarbonyloxy)succinimide (Fmoc-OSu), LiALH4, pyridine, N,Ntertrabutylammonium fluoride (TBAF), trifluoroacetic acid (TFA), ammonium formate, bovine
serum albumin (BSA), DL-dithiothreitol (DTT), iodoacetamide (IA) and 5-aminovaleric acid
were purchased from Sigma (St. Louis, MO). 2-{2-[2-(2-Amino-ethoxy)-ethoxy]-ethoxy}ethanol and [N- (ε –maleimidocaproyloxy) sulfosuccinimide ester] (Sulfo-EMCS) were
purchased from Molecular Bioscience, Inc (Boulder, CO).
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N-(3-dimethylaminopropyl)-N′-ethylcarbodiimide hydrochloride (EDCI) (Advanced ChemTech,
Louisville, KY). 1-hydroxybenzotriazole, anhydrous (HOBt) was purchased from Chem-Impex
International, Inc.(Wood Dale, IL). N,N′-disuccinimidyl carbonate (DSC), 1-Boc-piperazine
(Oakwood Products, Inc., West Columbia, SC), tetrabutylammonium fluoride (TBAF,) and
Tris(2-carboxyethyl) phosphine hydrochloride (TCEP hydrochloride) were purchased from EMD
Chemicals Inc. (Gibbstown, NJ). Diisopropylethylamine (DiPEA), and p-nitrophenylchloromate
were purchased from Acros (Raritan, New Jersey). ACTH (4-11) was purchased from American
Peptide Company, Inc. (Sunnyvale, CA). Sequencing grade modified trypsin was purchased
from Promega, Inc (Madison, WI). Fluorous silica gel (5 µm in diameter), 2H,2H,3H,3Hperfluoroundecanoic acid and 2-[2-(1H,1H,2H,2H-perfluorohexyl)
isopropoxycarbonyloxyimino]-2-phenylacetonitrile (F-BOC-ON) were purchased from Fluorous
Technologies Inc (Pittsburg, PA).
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Figure 3.1. Structures of synthesized fluorous labeling reagents A, B and C.
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3.4 Experimentals
3.4.1 Synthesis of fluorous labeing reagent (FBPNHS) (Scheme 3.1)
5-(4,4,5,5,6,6,7,7,8,8,9,9,10,10,11,11,11-heptadecafluoro-1,1-dimethylundecyloxycarbonylamino)-pentanoic acid (1’)
90.7 mg (0.77 mM, 1.05 eq) of 5-amino-pentanoic acid was taken up in 1.5 mL of
dichloromethane and 315 µL of diisopropylethylamine (2.5 eq) was added.
The stirred mixture was then cooled to 0° C in an ice bath. To this mixture was added 110 µL of
trimethylsilylchloride (0.87 mM, 1.2 eq) under nitrogen and the reaction was allowed to proceed
for 10 minutes. Then a solution of F-BOC-ON (500 mg, 0.73 mM, 1.0 eq) in 2 mL THF was
slowly added to the flask. The ice bath was removed to let the reaction continue for 10 hours at
room temperature. The reaction was quenched with 2mL of 2N HCl and extracted into ether 2-3
times. The organic layers are combined, dried over magnesium sulfate, followed by solvents
evaporation. The extracted product was purified by silica gel column chromatography with ethyl
acetate-hexane 1:3 as the elution solvent. Purified product 2 (464 mg, 98%) was obtained as
white solid 1’. 1H NMR (400 MHz, DMSO-d6) δ 1.34 (t, J=7.0 Hz, 2H), δ 1.38 (s, 6H), 1.44 (t,
J=7.0 Hz, 2H), 1.94 (t, J=7.0 Hz, 2H), 2.16 (t, J= 7.0 Hz, 4H), 2.88 (q, J=6.2 Hz ,2H), 6.94 (t,
J=5.1 Hz, 1H), 11.96 (s, 1H). ESI-MS: (M+H)+ =650.1.

1.2 5-(4,4,5,5,6,6,7,7,8,8,9,9,10,10,11,11,11-Heptadecafluoro-1,1-dimethylundecyloxycarbonylamino)-pentanoic acid 2,6-dioxo-piperidin-1-yl ester (FBPNHS) (2’’)
To a stirred solution of 2 (200 mg, 0.31 mM, 1.0 eq) was dissolved in 2mL anhydrous DMF, to
which DSC ( 158 mg, 0.62 mM, 2.0 eq) and pyridine ( 73 mg, 0.93 mM, 3.0 eq) were added. The
mixture was stirred overnight at room temperature and solvent was
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removed under vacuum. Crude product was purified by silica gel column with ethyl acetatehexane 2:1 as the elution solvent to give the pure product 3 (188 mg, 80%) as white solid 2’’. 1H
NMR (400 MHz, CDCl3) δ 1.48 (s, 6H), 1.59 (q, J=7.0 Hz, 2H), 1.75 (q, J=7.0 Hz, 2H), 2.12
(m, 2H), 2.75 (m, 6H), 3.15 (t, J=7.0 Hz, 2H), 4.80 (s, 1H). ESI-MS: (M+H)+ =761.1.

3.4.2 Labeling small peptides MRFA and ACTH (4-11) using FBPNHS
To avoid rapid hydrolysis of the compound, excessive amount of peptide was used in this study.
10µL of 153 mM MRFA aqueous solution was mixed with 50 µL of 2.5 mM FBPNHS THF
solution. The reaction proceeded at room temperature for one hour. 0.5 µL of mixture was
diluted in 60 µL of ethanol containing 5% FA and analyzed on the mass spectrometer through
direct infusion.

Longer peptides ACTH (4-11) were dissolved in DMF : NaHCO3 (50 mM in water) = 3: 1 (v/v,
pH=7.8). 9 µL of 50 mM ACTH (4-11) was mixed 20 µL of 50 mM FBPNHS in THF solution.
The mixture was set at room temperature for 1hour, followed by addition of 2 µL of 100 mM
Tris (in THF/H2O ,vol/vol=1/1) and mixing for 30 minutes at room temperature. The products
were dried under vacuum, and the fluorous tag was cleaved in 100 µL of ICAT cleavage reagents
according to the procedures described in the manufacture’s protocol (Applied Biosystems). After
1 hour, an aliquot of 1 µL solution was diluted to 100 µL of 50% MeOH for immediate ESI-MS
analysis.

3.4.3 Labeling a standard protein bovine serum albumin (BSA) using FBPNHS
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BSA (~0.7 nM, 20 µL) (Sigma-Aldrich, St Louis, MO) in the same solvents used in the peptide
labeling above was reacted with 15 µL of FBPNHS (1.5 µM) in THF solution with mixing at
room temperature. The reaction was allowed to proceed for 1 hour and quenched by adding 5µL
of 5 M Tris and mixing for 20 minutes. After solvents evaporation, 200 µL of the ICAT cleavage
reagents was added. The cleavage reaction was allowed to proceed for 2 hours at 37°C. After the
completion of the cleavage, solvents were evaporated, and the labeled BSA was re-dissolved in
50% MeOH and separated from excessive labeling reagents, which became insoluble in 50%
MeOH. The labeled BSA was vacuum dried and dissolved in 50 mM ammonium bicarbonate for
alkylation and trypsin digestion. Digested tryptic peptides were analyzed by LC-MS and by
database search as described below.

3.4.4 Synthesis of Sulfo-NHS-(OEG)3-perfluoroctane ( Scheme 3.2 to Scheme 3.5 )
4,4,5,5,6,6,7,7,8,8,9,9,10,10,11,11,11-heptadecafluoro-N-(2-(2-(2-(2hydroxyethoxy)ethoxy)ethoxy)ethyl)undecanamide (1)
EDCI (0.64 g, 3.3 mM, 1.1 eq) and HOBt (0.68 g, 4.5 mM, 1.5 eq) was added to a stirred
mixture of 2-(2-(2-(2-aminoethoxy)ethoxy)ethoxy)ethanol (0.62 g, 3.2 mM, 1.05 eq) and
4,4,5,5,6,6,7,7,8,8,9,9,10,10,11,11,11-heptadecafluoroundecanoic acid (1.50 g, 3.0 mM, 1.0 eq.)
in 20 mL anhydrous dichloromethane (CH2Cl2) at room temperature. After 16 hr stirring, the
solution was diluted by CH2Cl2, washed by saturated sodium bicarbonate, extracted by CH2Cl2.
Combined organic layer was washed by brine, dried over MgSO4 and concentrated under
reduced pressure. The crude product was purified by flash column chromatography (SiO2, eluent:
9:1 CH2Cl2/MeOH) as pale brown oil 1 (1.56 g, yield: 78%). 1H NMR (400 MHz, CDCl3) δ 2.49
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(m, 2H), 2.58 (m, 2H), 3.49 (t, J=5.0 Hz, 2H), 3.56 (t, J=5.1 Hz, 2H), 3.67 (m, 4H), 3.71 (m, 4H),
3.81 (t, J=6.0 Hz, 2H), 4.45 (t, J=6.0 Hz, 2H), 6.26 (s, 1H). ESI-MS: (M+H)+ =668.1.

16,16,17,17,18,18,19,19,20,20,21,21,22,22,23,23,23-heptadecafluoro-13-oxo-3,6,9-trioxa-12azatricosyl 4-nitrobenzoate (2)
4-nitrophenyl chlorofomate (0.72 g, 3.6 mM, 1.5 eq.) in 5mL anhydrous CH2Cl2 was slowly
added to a solution of c (1.4 g, 2.4 mM, 1.0 eq.) and DiPEA (0.93g, 7.2 mM, 3.0 eq.) in 15 mL
anhydrous CH2Cl2 at 4°C. The mixture was stirred for 16 hr while gradually warmed to the room
temperature. The reaction was quenched by adding ice-cold 0.5N HCl, extracted by CH2Cl2.
Organic layer was washed by H2O, brine, dried over MgSO4 and concentrated in vacuo. The
crude product was purified by flash column chromatography (SiO2, eluent: 1:1
hexane/ethylacetate) as pale yellow waxy solid 2 (1.80 g, yield: 90%). 1H NMR (400 MHz,
CDCl3) δ 2.46 (m, 2H), 2.49 (m, 2H), 3.47 (t, J=5.0 Hz, 2H), 3.57 (t, J=5.0 Hz, 2H), 3.65 (m,
4H), 3.70 (m, 4H), 3.81 (t, J=6.0 Hz, 2H), 4.44 (t, J=6.0 Hz, 2H), 6.25 (s, 1H), 7.38 (d, J=9.2 Hz,
2H), 8.28 (d, J=9.2 Hz, 2H). ESI-MS: (M+H)+ =817.1

4-amino-2-methyl-butan-2-ol (3)
To a vigorously stirred solution of LiAlH4 (2.8 g, 74 mM, 5.0 eq.) in 140 mL ice-cold dry ether
was slowly added 2-methylpent-4-yn-2-ol (1.45 g, 14.8 mM, 1.0 eqiv.) in 50 mL dry ether. After
stirring for 1 hour at room temperature, the mixture was refluxed for 10 hours. After cooling, 15
mL ice cold 10% NaOH was slowly added to the reaction under stirring to quench the reaction.
After additional 2 hour stirring, precipitates were filtered and washed thoroughly by 70 mL THF
three times. After removal of THF in vacuo, 80 mL of 15% NaOH was added to the residue
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followed by extraction of 90 mL DCM three times. Organic phase was combined, washed by
brine and dried over MgSO4 overnight. Solvents were evaporated to afford product as pale
yellow oil 3 (1.40g, yield: 92%), which was used for the next step without further purification.

(3-Hydroxy-3-methyl-butyl)-carbamic acid 9H-fluoren-9-ylmethyl ester (4)
Compound 3 (0.60 g, 5.8 mM, 1.0 eq ) was taken up in 20 mL 5% Na2CO3 and cooled off in an
ice-water slurry bath. Fmoc-Osu (2.16 g, 6.4 mM, 1.1 eq) in 25 mL THF was slowly added to the
mixture. After stirring for 16 hr, THF was removed in vacuo and the aqueous phase was
extracted by 70 mL DCM three times. The extracts were combined, washed by brine, dried over
MgSO4 and evaporated to dryness. Crude product was purified by flash column chromatography
(SiO2, eluent: 6:1 DCM/ethylacetate) as white solid 4 (1.75g, yield: 93 %). 1H NMR (400 MHz,
CDCl3) δ 1.27 (s, 6H), 1.71 (t, J=6.8 Hz, 2H), 3.64 (t, J=6.8 Hz, 2H), 4.22 (t, J=6.8 Hz, 1H), 4.38
(d, J=6.8 Hz, 2H), 5.37 (s, 1H), 7.31 (t, J=7.2 Hz, 2H), 7.40 (t, J=7.2 Hz, 2H), 7.60 (d, J=7.2 Hz,
2H), 7.76(d, J=7.2 Hz, 2H). ESI-MS: (M+H)+ =326.2

Carbonic acid 3-(9H-fluoren-9-ylmethoxycarbonylamino)-1,1-dimethyl-propyl ester 4nitro-phenyl ester (5)
To a solution of 4 (0.76 g, 2.3 mM, 1.0 eq) and pyridine (5 mL) in 25 mL DCM was slowly
added 4-nitrophenyl chlorofomate (0.94 g, 4.6 mM, 2.0 eq) in 9 mL DCM at 0°C. The mixture
was stirred for 8 hours at room temperature and poured into 90 mL 0.5 N cold HCl. 300 mL
DCM was used for 3 times of extraction and the extracts were washed by brine, dried over
MgSO4 before evaporated to dryness. Crude product was purified by flash column
chromatography (SiO2, eluent: 5:1 hexane/ethylacetate) as colorless to light yellow oil 5 (1.10 g,
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yield: 96%). 1H NMR (400 MHz, CDCl3) δ 1.60 (s, 6H), 2.07 (t, J=7.6 Hz, 2H), 3.40 (t, J=7.6
Hz, 2H), 4.22 (t, J=6.8 Hz, 1H), 4.42 (d, J=6.8 Hz, 2H), 4.93 (s, 1H), 7.28 (t, J=7.2 Hz, 2H), 7.23
(t, J=7.2 Hz, 2H), 7.35 (d, J=8.4 Hz, 2H), 7.40 (t, J=7.2 Hz, 2H), 7.58 (d, J=7.2 Hz, 2H), 7.76 (d,
J=7.2 Hz, 2H), 8.24 (d, J=8.4 Hz, 2H). ESI-MS: (M+H)+ =491.2

Bis(2,5-dioxopyrrolidin-1-yl) 3,3'-disulfanediyldipropanoate (6)
To a solution of 3,3'-disulfanediyldipropanoic acid (50 mg, 0.24 mM, 1.0 eq) and pyridine (0.11
mL, 6.0 eq) in 3mL DCM was added DSC (182 mg, 0.72 mM, 3.0 eq). The mixture was stirred
for at room temperature overnight then diluted by 10 mL DCM before poured into 10 mL 0.2 N
cold HCl. Additional 50 mL DCM was used for extractions and the extracts were washed by
brine, dried over MgSO4 before evaporated to dryness. Crude product was purified by flash
column chromatography (SiO2, eluent: 2:3 hexane/ethylacetate) as white solid 6 (89 mg, yield
93%). ESI-MS: (M+H)+ =405.53

Di-tert-butyl 4,4'-(3,3'-disulfanediylbis(propanoyl))bis(piperazine-1-carboxylate) (7)
To a solution of 6 (0.5 g, 1.23 mM, 1.0 eq) and DiEA (0.47 mL) in 11 mL DCM was slowly
added tert-butyl piperazine-1-carboxylate (0.51 g, 2.72 mM, 2.2 eq) in 5 mL DCM at room
temperature. After 3 hours stirring, solvents were evaporated and crude product was recrystalized
by hexane/ethylacetate as white solid 7 (0.62 g, yield: 94%). 1H NMR (400 MHz, CDCl3) δ 1.47
(s, 18H), 2.76 (t, J=6.8 Hz, 4H), 2.97 (t, J=6.8 Hz, 4H), 3.46 (m, 8H), 3.48 (t, J=4.9 Hz, 4H),
3.60 (t, J=4.9 Hz, 4H). ESI-MS: (M+H)+ =546.4
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Bis(4-((((9H-fluoren-9-yl)methoxy)carbonyl)amino)-2-methylbutan-2-yl) 4,4'-(3,3'disulfanediylbis(propanoyl))bis(piperazine-1-carboxylate) (8)
Compound 7 (0.5 g, 0.91 mM, 1.0 eq.) was taken up by 2.5 mL of 50% TFA in DCM under
stirring at room temperature. After 1 hour cleavage reaction, solvents were evaporated under
reduced pressure and the resulting residue was mixed with 6 mL DCM, 1.7 mL DiEA and HOBt
(27.6 mg, 0.20 eq). To this mixture was added compound 5 (0.98 g, 2.0 mM, 2.2 eq) in 5 mL
DCM. After stirring for 16 hours, 30 mL of 0.5 N cold HCl was added to quench the reaction and
200 mL DCM was then used for 3 times of extractions. The extracts were washed by brine, dried
by MgSO4 and evaporated to dryness. Crude product was purified by flash column
chromatography (SiO2, eluent: ethylacetate) as white solid 8 (0.7 g, yield: 73%). 1H NMR (400
MHz, CDCl3) δ 1.49 (s, 12H), 2.30 (t, J=6.8 Hz, 4H), 2.74 (t, J=7.0 Hz, 4H), 2.95 (t, J=7.0 Hz,
4H), 3.28 (t, J=6.8 Hz, 4H), 3.41 (m, 4H), 3.44 (m, 8H), 3.57 (m, 4H), 4.20 (t, J=6.4 Hz, 2H),
4.40 (d, J=6.4 Hz, 4H), 4.80 (s, 2H), 7.31 (t, J=7.6 Hz, 4H), 7.40 (t, J=7.6 Hz, 4H), 7.58 (d, J=7.6
Hz, 4H), 7.62 (d, J=7.6 Hz, 4H). ESI-MS: (M+H)+ =1049.4

23,23,24,24,25,25,26,26,27,27,28,28,29,29,30,30,30-heptadecafluoro-2-methyl-6,20-dioxo7,10,13,16-tetraoxa-5,19-diazatriacontan-2-yl 4-(3-((3-(4(24,24,25,25,26,26,27,27,28,28,29,29,30,30,31,31,31-heptadecafluoro-3,3-dimethyl-7,21dioxo-2,8,11,14,17-pentaoxa-6,20-diazahentriacontan-1-oyl)piperazin-1-yl)-3oxopropyl)disulfanyl)propanoyl)piperazine-1-carboxylate (9 )
To a solution of 8 in 0.7 mL anhydrous DMF was added 66 mg TBAF. After 2 hours, TLC
showed complete de-protection and compound 2 (135 mg, 0.16 mM, 2.0 eqiv.) in 4 mL
anhydrous DCM was slowly added at room temperature, followed by addition of DiEA (0.03
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mL). The mixture was stirred overnight, and then the reaction was quenched by adding 10 mL
ice cold 0.2 N HCl. The separated aqueous phase was further extracted by 60 mL DCM 3 times.
The extracts were washed by brine, dried by MgSO4 and evaporated to dryness. Crude product
was purified by flash column chromatography (SiO2, eluent: 13:1 DCM: MeOH) as pale oil 9
(135 mg, yield: 84 %). 1H NMR (400 MHz, CDCl3) δ 1.47 (s, 12H), 2.00 (t, J=7.2 Hz, 4H), 2.47
(m, 4H), 2.51 (m, 4H), 2.76 (t, J=7.1 Hz, 4H), 2.95 (t, J=7.0 Hz, 4H), 3.25 (q, J=7.2 Hz, 4H),
3.40 (m, 16H), 3.56 (t, J=5.0 Hz, 4H), 3.60 (m, 24H), 4.19 (t, J=5.0 Hz, 4H), 4.99 (s, 2H), 6.63
(s, 2H). ESI-MS: (M+H)+ =1991.5

23,23,24,24,25,25,26,26,27,27,28,28,29,29,30,30,30-heptadecafluoro-2-methyl-6,20-dioxo7,10,13,16-tetraoxa-5,19-diazatriacontan-2-yl 4-(3- mercaptopropanoyl)piperazine -1carboxylate (10)
0.6 mL of TCEP.HCl (65 mg, 0.23 mM, 4.0 eq ) in saturated NaHCO3 was added to 3 mL THF
solution of compound 9 (113 mg, 0.057 mM, 1.0 eq). After stirring for 9 hours, solvents were
evaporated under reduced pressure. The crude product was purified by flash column
chromatography (SiO2, eluent: 20:1 DCM: MeOH) as pale brown oil 10 (52 mg, yield: 93%). 1H
NMR (400 MHz, CDCl3) δ 1.47 (s, 6H), 1.73 (t, J=8.0 Hz, 1H), 2.00 (t, J=7.2 Hz, 2H), 2.49 (m,
2H), 2.52 (m, 2H), 2.65 (t, J=6.8 Hz, 2H), 2.81 (q, J=7.2 Hz, 2H), 3.24 (q, J=7.2 Hz, 2H), 3.40
(m, 8H), 3.56 (t, J=5.2 Hz, 2H), 3.63 (m, 12H), 4.19 (t, J=5.2 Hz, 2H), 4.99 (s, 1H), 6.63 (s, 1H).
ESI-MS: (M+H)+ =997.3

Sodium 1-((6-(3-((3-(4-(24,24,25,25,26,26,27,27,28,28,29,29,30,30,31,31,31-heptadecafluoro3,3-dimethyl-7,21-dioxo-2,8,11,14,17-pentaoxa-6,20-diazahentriacontan-1-oyl)piperazin-1-
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yl)-3-oxopropyl)thio)-2,5-dioxopyrrolidin-1-yl)hexanoyl)oxy)-2,5-dioxopyrrolidine-3sulfonate (Sulfo-NHS-(OEG)3-perfluoroctane) (11)
To a solution of 10 (10 mg, 24 mM, 1.0 eq.) in anhydrous DMF was added Sulfo-EMCS (25.5
mg, 25.6 mM, 1.05 eq) and the mixture was stirred at room temperature for 1hour and then for
additional 3 hours at 40°C. Solvents were removed under reduced pressure and final product 11
was obtained as pale yellow waxy solid. 1H NMR (400 MHz, DMSO-d6) δ 1.30 (q, J=7.2 Hz,
2H), 1.38 (s, 6H), 1.49 (q, J=7.2 Hz, 2H), 1.60 (q, J=7.2 Hz, 2H), 1.84 (t, J=7.6 Hz, 2H), 2.41
(m, 4H), 2.44 (t, J=7.2 Hz, 2H), 2.62 (t, J=6.8 Hz, 2H), 2.70 (m, 2H), 2.84 (m, 2H), 3.02 (m, 2H),
3.20 (q, J=6.0 Hz, 2H), 3.30~3.51 (m, 24H), 4.02 (m, 4H), 7.18 (t, J=5.6 Hz, 1H), 8.12 (t, J=5.6
Hz, 1H). Negative ion ESI-MS: (M-H)-=1383.2.

3.4.5 Synthesis of sulfo-NHS-(OEG)1-perfluoroctane (B in Figure 3.1)
The compound sulfo-NHS-(OEG)1-perfluoroctane was synthesized according to the procedures
above for synthesizing its analogue except that (OEG)1 was used instead of (OEG)3. The
chareacterizations of all intermediates from synthesizing the final product sulfo-NHS-(OEG)1perfluoroctane by 1HNMR and ESI-MS are listed below:

4,4,5,5,6,6,7,7,8,8,9,9,10,10,11,11,11-heptadecafluoro-N-(2-(2hydroxyethoxy)ethyl)undecanamide
O
C8F17
1

N
H

O

OH

H NMR (400 MHz, CDCl3) δ 2.49 (m, 2H), 2.56 (m, 2H), 3.50 (t, J=4.8 Hz, 2H), 3.58 (t, J=4.8

Hz, 2H), 3.59 (t, J=4.4 Hz, 2H), 3.76 (t, J=4.4 Hz, 2H), 6.21 (s, 1H). ESI-MS: (M+H)+ =580.1.
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2-(2-(4,4,5,5,6,6,7,7,8,8,9,9,10,10,11,11,11-heptadecafluoroundecanamido)ethoxy)ethyl (4nitrophenyl) carbonate
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H NMR (400 MHz, CDCl3) δ 2.49 (m, 2H), 2.56 (m, 2H), 3.55 (t, J=4.8 Hz, 2H), 3.62 (t, J=4.8

Hz, 2H), 3.78 (t, J=4.4 Hz, 2H), 4.45 (t, J=4.4 Hz, 2H), 5.99 (s, 1H), 7.38 (d, J=9.2 Hz, 2H), 8.28
(d, J=9.2 Hz, 2H). ESI-MS: (M+H)+ =745.08.

17,17,18,18,19,19,20,20,21,21,22,22,23,23,24,24,24-heptadecafluoro-2-methyl-6,14-dioxo7,10-dioxa-5,13-diazatetracosan-2-yl 4-(3-((3-(4(18,18,19,19,20,20,21,21,22,22,23,23,24,24,25,25,25-heptadecafluoro-3,3-dimethyl-7,15dioxo-2,8,11-trioxa-6,14-diazapentacosan-1-oyl)piperazin-1-yl)-3oxopropyl)disulfanyl)propanoyl)piperazine-1-carboxylate
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H NMR (400 MHz, CDCl3) δ 1.47 (s, 12H), 2.02 (t, J=7.2 Hz, 4H), 2.47 (m, 4H), 2.51 (m, 4H),

2.76(t, J=7.0 Hz, 4H), 2.95 (t, J=7.0 Hz, 4H), 3.27 (q, J=7.2 Hz, 4H), 3.45 (m, 16H), 3.56 (t,
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J=5.0 Hz, 4H), 3.60 (m, 8H), 4.20 (t, J=5.0 Hz, 4H), 4.88 (s, 2H), 6.50 (s, 2H). ESI-MS: (M+H)+
=1815.4

17,17,18,18,19,19,20,20,21,21,22,22,23,23,24,24,24-heptadecafluoro-2-methyl-6,14-dioxo7,10-dioxa-5,13-diazatetracosan-2-yl 4-(3-mercaptopropanoyl)piperazine-1-carboxylate
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Negative ion ESI-MS: (M-H)- =1295.3

3.4.6 Labeling ACTH (4-11) using sulfo-NHS-(OEG)3-perfluoroctane
10 µL of 1mg/mL ACTH (4-11) was diluted in 120 µL PBS 8.0 and the solution was added to a
vial containing 0.038 mg labeling reagent (Sulfo-NHS-(OEG)3-perfluoroctane, structure see C in
Figure 3.1). The labeling was proceeded at room temperature for 2 hours and then excessive
labeling reagent was consumed by reacting with about 0.5 mg polymer-bound tris(2aminoethyl)-amine for additional 1hour at room temperature. After centrifugation, the polymer
beads were washed by 100 µL 80% MeOH and 100% MeOH twice, supernatants were
combined. 1 µL of the collected supernatant was resuspended in 100 µL 2.5% FA in MeOH for
direct ESI-MS analysis. The rest was vacuum dried and resuspended in 50 µL TFA for cleavage.
The cleavage reaction was completed after 1 hour at 37° C. After removal of the TFA under
reduced pressure, residues were dissolved in 100 µL 50% MeOH containing 2.5% FA for ESIMS analysis.

3.4.7 Labeling BSA using sulfo-NHS-(OEG)3-perfluoroctane and affinity purification of the
labeled tryptic BSA peptides
10 µL of 10 mg/mL BSA stock solution was diluted in 35 µL PBS 8.0 buffer and the solution
was transferred to a vial containing 0.26 mg fluorous reagent, followed by a brief vortex. The
mixture was incubated for 2 hours at room temperature while shaking. The excessive labeling
reagent was consumed by adding 15 µL of 50 mM tris-HCl for additional 1 hour mixing. The
labeled BSA was then subjected to in solution trypsin digestion. Briefly, 80 µL of 8.0 M urea
was added to the labeling mixture, followed by addition of 1.7 µL of 200 mM DTT in 50 mM
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ammonium bicarbonate for 1hour reduction at 45°C. 6 µL of 200 mM iodoacetamidein 50 mM
ammonium bicarbonate was added for 1hour alkylation at room temperature in dark, and the
excessive iodoacetamide was consumed by adding 6 µL DTT for an additional 1 hour incubation
at room temperature. The mixture was diluted by adding 1 mL of 50 mM ammonium
biocarbonate to final before trypsin (6 µg) digestion at 37° C for 15 hours. The digestion was
stopped by adding 5% FA till colorless precipitates occurred ( pH≈3.0, hydrolysis by-product of
the labeling reagent.), which was then separated by centrifugation and further were washed by
200 µL 5% FA. Combined supernatant were evaporated to dryness and 1/6 sample was
resuspended in 450 µL buffer A (20 mM ammonium formate, 0.1 M Acetic acid in 60% MeOH)
for fluorous affinity purification. Tryptic BSA mixture was loaded onto cartridge packed by
fluorous silica gel beads at a flow rate 10 µL/min using a syringe pump. After washing by buffer
A (3 mL) and retained modified peptides were eluted by 2 mL buffer B (20 mM ammonium
formate, 0.1 M acetic acid in 100% MeOH) at the flow rate of 10 µL/min. The eluate was dried
under vacuum and resuspended in 95% TFA with 5% anisole as a scavenger for incubation at
37°C for 2 hours. After removal of solvents, cleaved peptides were resuspended in 50 µL of 5%
FA, 2% ACN for ESI-LC-MS analysis.

3.4.8 LC-MS/MS analysis and database search
LC-ESI MS/MS was performed on a Finnigan LTQTM-ion trap mass spectrometer (Thermo
Electron, San Jose, CA). Peptide sample (8 µl) was first loaded to a C18 trap column and washed
with 3% acetonitrile and 0.1% formic acid for 60 minutes for desalting, then the peptides were
eluted to a reverse-phase C18 analytical column by a 60 minutes gradient made of A buffer (0.1%
formic acid: 97% water:3% acetonitrile v/v/v) and B buffer (0.1% formic acid: 3% acetonitrile:
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97% water v/v/v) at a flow rate of 200 ~ 500 nL/min. Separated peptides were analyzed by the
data-dependent acquisition mode set by Xcalibur, 2.2 version (Thermo Electron, San Jose, CA).
After a MS survey scan over the m/z range of 300-2000, the seven most intensive precursors
were selected and subjected to fragmentation by CID (collision induced dissociation). The
normalized collision energy was set at 35% with activation Q value being 0.25 and dynamic
exclusion of 100 seconds. The acquired raw data were processed by BioWorks software, version
3.3(Thermo Electron). Parameters for SEQUEST database search were set as follows:
differential mass increase of 57.02 Da on cysteinyl, 15.99 Da on methionine residue, 367.02 Da
(for Sulfo-NHS-(OEG)3-perfluoroctane labeling) and 99.06 Da (for FBPNHS labeling) on lysine
residue respectively. The number of missed cleavage sites was set to three. The search results
were filtered by cross-correlation score (XCorr) which must be ≥ 2.0 for singly charged ions, 2.5
for the doubly charged, 3.0 for the triply charged and by delta correlation score (∆Cn) ≥ 0.1.
MS/MS spectra for detected modified peptides were manually examined to ensure quality of
identification.

3.5 Results and discussion
3.5.1 Synthesis of fluorous labeling reagent Boc-pentanoic-NHS-perfluoroctane (FBPNHS)
The design of our 1st fluorous labeling reagent included fluorous tag (C8F17) moiety for affinity
enrichment, a reactive group (HOSu derived active ester, NHS ester) targeting free amine groups
and a TFA labile carbamate linker. The NHS ester was chosen as the reactive group because of
its well known ability to react with NH2 groups in peptides and proteins in pH=7-9 buffer. The
carbamate group was selected as the cleavable linker based on robust chemistry and easy
incorporation into the reagent. Moreover, a relatively long spacer (5 carbon backbone) would
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reduce the steric hindrance around the NHS ester. The condition that favors the linker cleavage
was similar to TFA cleavage of the Boc protected amino acids, which has been routinely
employed in peptide synthesis. The compound was synthesized following the two steps shown in
Scheme 3.1 with an overall 78% yield.

The first step – production of fluorous tagged Boc group, was relatively easy with high yield.
The second step however, was not as straightforward. A variety of reaction conditions such as
using coupling reagents (e.g. DCC, EDC) in the presence of organic bases (e.g. pyridine, DMAP
and DiPEA) had been explored, but none of those approaches resulted in acceptable
condensation efficiency as monitored by TLC and mass spectrometry. The efficiency was
significantly enhanced when NHS was replaced by DSC, an activated derivative of of HOSu,
which had been utilized in the preparation of active ester (15) and peptide synthesis. Presumably,
the NHS anions are more easily generated from the attack of carboxylic groups to the carbonyl in
DSC, which was proven to be more reactive toward deprotonated carboxyl group in the presence
of pyridine.

3.5.2 Labeling peptides and BSA using FBPNHS
As proof of principle experiments, the newly synthesized reagent was tested in the labeling of
some small peptides. After about 30 minutes labeling reaction, a small peptide MRFA gave a
new peak at m/z: 1155.3, which corresponded to the N-terminally labeled MRFA, the
unconsumed MRFA at m/z: 524.4 also appeared in the same mass spectrum (Figure 3.2).
Increasing the amount of the labeling reagent resulted in complete conversion of MRFA to its
labeled form (mass spectral data not shown). It is interesting that the cleavage of carbamate
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Figure 3.2. MS spectrum of a modified small peptide MRFA by Boc-pentanoic-NHSperfluoroctane after one hour reaction at room temperature. The ion at m/z 524.4 corresponds to
the unconsumed MRFA and the ion at m/z 1155.3 represents N-terminal modified MRFA.
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linker was preferred to peptide bond cleavage upon CID (collision induced dissociation). It is
also noteworthy that no fragmentation of fluorous tag was observed under the CID conditions
that were optimized for peptide fragmentation; this phenomenon confirmed the inertness of the
fluorous tag in MS analysis (2).

Longer peptide ACTH (4-11) was also tested and trifluoroacetic acid (TFA) was employed to
cleave the cabamate linker in the labeled peptides. Results indicated that both the N-terminal and
the lysine side chain of the peptides were modified as evidenced
by the appearance of two ions after the cleavage at m/z: 1189.6 (singly tagged) and 1288.7
(doubly tagged) (Figure 3.3). Its MS/MS analysis (Figure 3.4) revealed that
C-terminal lysine residue was preferentially modified over the N-terminus in ACTH (4-11)
possibly because of free amines from the lysine side chain were more accessible to the labeling
reagent than the ones at N-terminus.

The labeled BSA was digested by trypsin, and the tryptic peptide mixture was treated by ICAT
cleavage reagents to remove the bulky fluorous label. HPLC-MS analysis followed by database
search against the amino acid sequence of BSA resulted in the identification of 33 peptides
among which 11 peptides were labeled by FBPNHS. The FBPNHS labeled peptides covered
nearly 26% of the BSA sequence (highlighted in blue in Figure 3.5).
Moreover, a small moiety after the cleavage does not appear to interfere with the peptide
backbone fragmentation pattern without producing its visible fragments in MS/MS spectrum as
exemplified in Figure 3.6.
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Figure 3.3. MS analysis a modified peptide ACTH (4-11) by Boc-pentanoic-NHSperfluoroctane after cleaving the fluorous tag. 1090.6 (m/z) indicates the unconsumed peptide
ACTH (4-11), 1189.6 (m/z) represents the singly tagged ACTH (4-11) and 1288.7524.4 (m/z)
corresponds to the doubly tagged ACTH (4-11).
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Figure 3.4. MS2 analysis of singly tagged ACTH (4-11) peptide precursor ion at m/z 1189.6.
Series of b ions and y ions could be used to confirm the peptide’s sequence.
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Figure 3.5. Peptides (highlighted in blue) modified by Boc-pentanoic-NHS-perfluoroctane in
BSA. The fluorous tag moiety was cleaved before LC-MS analysis.
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Figure 3.6. MS2 spectrum of a BSA tryptic peptide modified by Boc-pentanoic-NHSperfluoroctane. The bulky fluorous tag moiety was cleaved before LC-MS analysis.

3.5.3 Retrosynthetic analysis of 2nd generation fluorous labeling reagent sulfo-NHS(OEG)3-perfluoroctane
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The novel fluorous labeling reagent, sulfo-NHS-(OEG)3-perfluoroctane can be divided to five
building blocks (a in Figure 3.7). The synthesis of this labeling reagent was based on a
retrosynthetic analysis (b in Figure 3.7). The target product, sulfo-NHS-(OEG)3-perfluoroctane,
can be obtained through a highly efficient coupling reaction between 1 (Sulfo-EMCS, block E in
Figure 3.7 a) and a thiol compound 2 (block A to D) (in Figure 3.7 a), which could be derived
from the cleavage of a disulfide bond in its dimmer, compound 3. Compound 3 could be formed
through a carbamate formation between 4
and carbonate compound 5 after removal of the Fmoc group with TBAF in DMF. The acid labile
linker in compound 4 could be constructed through carbonate compound 7 (10) and piperazine
derivative 6, which be easily prepared from dithiobis[succinimidylpropionate] 9 and 1-Bocpiperazine 10. Compound 5 could be prepared from hydroxyl compound 8 by reacting with pnitrophenylchloroformate. The (OEG)3 spacer in compound 8 could be introduced by the
incorporation of (OEG)3-mono-amine 12 to fluorous compound 11 via an amide bond
formation. The fluorous labeling reagent was synthesized via a 10-step reaction with an overall
yield of 25%.

3.5.4 Characterization of sulfo-NHS-(OEG)3-perfluoroctane by Negative ESI-MS
The newly synthesized sulfo-NHS-(OEG)3-perfluoroctane was characterized by negative
electrospray mass spectrometry and 1H NMR (see detailed data in experimental), Dissolved in
50% MeOH, the labeling reagent could be detected in negative ion mass spectrometry as shown
in Figure 3.8. Upon collision induced dissociation (CID), the molecular ion [Sulfo-NHS-(OEG)3perfluoroctane]- at m/z 1383.30 yielded to two major product ions at m/z 605.0 and m/z 560.90
(Figure 3.8) corresponding to the product ion (Figure 3.8) from the cleavage at the carbamate
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bond in block C (Figure 3.7) and subsequent loss of a CO2 (block D and E in a Figure 3.7)
respectively. Further fragmentation of product ion at m/z 605.0 yielded ion at m/z 560.90 (Figure
3.8) after the neutral loss of a CO2. The product ion at m/z 560.90 in the MS2 spectrum of m/z
1383.30 and the m/z 560.90 in the MS3 spectrum of m/z 605.0 are the same, both ions yielded
m/z 387.01 (spectrum not shown) upon CID, corresponding to the formation of Sulfo-EMCS as
the result of thiol ether bond cleavage (block E in Figure 3.7 a). These mass spectral evidences
support the structure of newly synthesized sulfo-NHS-(OEG)3-perfluoroctane as shown in Figure
3.1 C.

3.5.5 MS2 analysis of ACTH (4-11) labeled by sulfo-NHS-(OEG)3-perfluoroctane
Sulfo-NHS-(OEG)3-perfluoroctane was employed to label a small peptide ACTH(4-11) (NH2M-E-H-F-R-W-G-K) in PBS buffer at room temperature. In a 1 hour reaction, the free amine
groups (N-terminal and lysine side chain) in ACTH (4-11) were almost completely tagged by the
labeling reagent (the molecular ion of intact ACTH disappeared and doubly labeled ACTH
became a major ion on the mass spectrum of the reaction mixture, data not shown). The bulky
part (correspond to building blocks A + B + C in Figure 3.7 a) of the labeling reagent was
removed from the labeled ACTH peptide upon treatment with TFA as expected, leaving a small
tag of 367.17 Da (net mass increase to the amine group in the peptide by building blocks D + E
after losing the sulfo-NHS group in Figure 3.7 a) remained covalently linked to the N-terminal
and lysine side chain amine of the peptide. The positive ion ESI MS/MS spectrum of the labeled
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Figure 3.7. Retrosynthetic analysis of sulfo-NHS-(OEG)3-perfluoroctane. a. Structure of
synthesized the fluorous labeling reagent with indications of its building blocks (A to E). b.
Retrosynthetic steps for the construction of sulfo-NHS-(OEG)3-perfluoroctane.
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ACTH peptide (after TFA cleavage) is shown in Figure 3.9. Most of the b ions and y ions can be
observed. Interestingly, a fragment ion at m/z 368.1 which corresponds to the residual of sulfoNHS-(OEG)3-perfluoroctane cleaved from the amide bonds formed during the labeling, also
appeared on the MS2 spectrum and could serve as a marker of the labeling and fluorous tag
moiety removal processes. The newly synthesized fluorous labeling reagent indeed efficiently
modified the free amine groups in peptide. The residual of sulfo-NHS(OEG)3-perfluoroctane after acid cleavage did not interfere with the fragmentation of the labeled
peptide.

3.5.6 MS2 analysis of BSA peptides labeled by sulfo-NHS-(OEG)3-perfluoroctane
To further demonstrate the potential of the Sulfo-NHS-(OEG)3-perfluoroctane in protein/peptide
modification, it was employed to label BSA in PBS buffer. No precipitation was observed
throughout the labeling reaction, which indicated that the labeling can be performed in aqueous
solution without introducing any organic solvent to the reaction mixture. After the trypsin
digestion, the tagged peptides were easily enriched through fluorous affinity purification. After
TFA cleavage as mentioned above, the tagged peptides were analyzed by LC-MS/MS. About
95% of the identified peptides were tagged (see Table 3.1). This indicates that affinity
purification based on fluorine-fluorine interaction was indeed highly effective in enriching
labeled peptides with low nonspecific binding. The sulfo-NHS-(OEG)3-perfluoroctane tagged
peptides had longer retention time on reversed-phase C18 column due to the increased
hydrophobicity introduced by the fluorous alkyl chain. Once the fluorous tag moiety was
removed, the tagged peptide behaved in the same way as its unmodified counterpart in reversed-
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phased LC separation. Fifteen out of sixteen tryptic peptides (see Table 3.1) were identified as
tagged peptides in a single LC-MS/MS experiment followed by database search against BSA
sequence using SEQUEST algorithm. As shown in Figure 3.10, the residual of fluorous tag had
little influence on the fragmentation of the labeled BSA peptide. In addition to the b ions and y
ions from peptides fragmentation, a characteristic ion at m/z 368.1 appeared on the spectrum
confirmed that this peptide was labeled by the fluorous reagent.

3.6 Conclusion
A serial of fluorous labeling reagents were synthesized with aim to effectively react with free
amine groups on peptides and proteins. The first labeling reagent Boc-pentanoic-NHSperfluoroctane (FBPNHS) was synthesized through 2 steps with an overall 78% yield. The
reactivity of FBPNHS with small peptides (MRFA and ACTH) was tested in water/organic
mixtures under slight basic conditions. ESI-MS analysis of the product mixture confirmed the
labeling reaction and MS2 spectrum of the labeled peptide showed that it was normally
fragmented after removal of the fluorous tag. As one of our novel 2nd generation fluorous
labeling reagents, sulfo-NHS-(OEG)3-perfluoroctane was also synthesized through 11 steps of
simple chemical reactions with a high overall yield of 23%. Sulfo-NHS-(OEG)3-perfluoroctane
also reacts with free amine groups from peptide/protein through an active succinimidyl ester
group. Notably, the labeling reaction proceeded efficiently in PBS buffer without the need of any
extra organic solvent in the reaction mixture. More importantly, a homogeneous solution of
reaction mixture was consistently observed throughout the labeling process, which indicated that
the fluorous labeling reagent was not only soluble in water, but also didn’t cause any aggregation
of the labeled proteins due to the incorporation of a hydrophilic (OEG)3 linker. Fluorous affinity
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Figure 3.9. Positive ion MS2 of peptide ACTH(4-11) tagged by the labeling reagent sulfo-NHS(OEG)3-perfluoroctane after TFA cleavage. The peptide was labeled at the N-terminal and the
lysine side chain. ▲ unique fragment ion at 368.2 m/z from the residual of the cleaved tag.
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Table 3.1. Identified tryptic peptides derived from sulfo-NHS-(OEG)3-perfluoroctane labeled
BSA*

Detected peptides from elution

Xc

K.NYQEAK*DAFLGSFLYEYSR.R
R.ADLAK*YIC@DNQDTISSK.L
K.GLVLIAFSQYLQQC@PFDEHVK.L
R.ADLAK*YIC@DNQDTISSK*LK.E
R.LAK*EYEATLEEC@C@AK.D
K.EAC@FAVEGPK*LVVSTQTALA
K.FWGK*YLYEIAR.R
R.K*VPQVSTPTLVEVSR.S
K.SLHTLFGDELC@K*VASLR.E
R.ETYGDMADC@C@EK*QEPER.N
K.VTK*C@C@TESLVNR.R
R.ETYGDMADC@CEK*QEPER.N
R.ETYGDM#ADC@CEK*QEPER.N
R.ALK*AWSVAR.L
R.C@ASIQK*FGER.A
R.C@C@TK*PESER.M

6.22
6.14
5.80
5.55
5.16
4.86
4.43
4.32
4.28
4.17
3.79
3.67
3.56
3.39
3.02
2.64

*Bulky perfluoroctane moiety and OEG linker of the labeling reagent was removed by acid
cleavage, which resulted in a net mass increase of 367.12 Da on lysine residue. * lysine residue
modified by fluorous affinity tag, #methionine was oxidized, and @ cysteine was modified by
iodoacetamide.
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Figure 3.10. Positive ion MS2 of a typical BSA tryptic peptide tagged by the labeling reagent
sulfo-NHS-(OEG)3-perfluoroctane at the lysine residue
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purification was performed to isolate the tagged tryptic peptides of BSA, majority of peptides
eluted from the fluorous affinity column were identified by LC-MS analysis as labeled peptides.
Once the bulky fluorous tag moiety and the OEG linker were removed by acid cleavage, the
labeled peptides (with a small residue from the fluorous labeling reagent) behaved similar to
those unlabeled peptide in terms of fragmentation pattern. All these results indicate that labeling
proteins/peptides by the newly synthesized sulfo-NHS-(OEG)3-perfluoroctane followed by
affinity separation/enrichment can by incorporated into most of LC-MS based proteomic
approaches.
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CHAPTER 4

Surface Exposed Peptide Segments of Candida albicans Cell Wall Proteome
Characterized by in vitro and in vivo Chemical Labelings and LC-MS

4.1 Abstract
The fungal pathogen Candida albicans is one of the major causes of candidiasis which results in
high mortality among various immunocompromised hosts (such as AIDS patients). Cell wall
proteins (CWPs) play essential functions in this pathogen’s colonization, invasion and induction
of immune response from hosts. Information on the dynamic regulations of CWPs during the
morphological transition from yeast to hyphae provides better understanding on the mechanism
of pathogen-host interaction. Cell surface biotinylations at low temperature (4°C), enzymatic
digestion of the intact fungal cell surface proteins (“whole cell shaving”), biotin-avidin affinity
enrichment of biotinylated peptides, liquid chromatography mass spectrometry (LC-MS) based
proteomic approach were employed for unambiguous identification of cell wall/cell wall
associated proteins and the exposed peptide segments of these proteins. SILAC (Stable Isotope
Labeling by Amino acids in Cell Culture) based CWP quantification analyses were performed to
monitor CWP accumulation level change in response to germination. 148 CWPs of yeast form of
C. albicans were identified based on stringent criteria through intact cell labeling by three
biotinylation labeling reagents. Characteristic fragments originated from biotin tag on tandem
mass spectra of labeled peptides were also employed to verify that the peptides were indeed
labeled. Notably, fifty one proteins found in our study were not reported in the literature as
CWPs or cell wall associated proteins. Metabolic labeling of proteins with isotopic coded lysine
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during yeast germination followed by and SDS-DTT (sodium dodecyl sulfate-dithiolthreitol)
extraction allowed us to quantify one hundred and eighteen cell wall-associated proteins, among
which ninety two proteins were up-regulated and twenty four proteins were down-regulated with
one yeast specific protein and one hyphae specific protein. Surface exposed peptide segments of
CWPs determined in this study could be new candidates to the pool of potential peptide targets
for protective vaccine development.
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4.2 Introduction
The cell surface of C. albicans is the frontier where initial interaction takes place between the
fungus and the host. Cell surface proteins are likely those members in cell wall matrix to initiate
fungal adhesion, colonization, pathogenic invasion and therefore modulation of immunological
response from the host (68). Studying the surface proteome of C. albicans is essential for gaining
a further understanding on the mechanism of the host-pathogen interactions. A paradigmatic
approach was established to profile the surface proteins in fugal species using Saccharomyces
cerevisiae as a model (93), featuring protein extraction via an array of chemical/enzymatic
means, protein separation by sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDSPAGE) and protein detection by mass spectrometry (MS) (66). With the recent advancement in
mass spectrometry based proteomic techniques, especially the coupling of MS and SDS-PAGE
and/or liquid chromatography (LC), characterization of fungal cell surface proteins has reached
an unprecedented level both qualitatively and quantitatively. For instance, non-gel based
methods were complementary to 2D-SDS-PAGE, which was not efficient in glycoprotein
separation (31, 92). A “whole cell-shaving” technique using proteolytic enzymes (usually
trypsin) was employed to release peptides from surface accessible proteins of Cryptococcus
neoformans (22) without the need of laborious protein extraction procedures. Moreover, labeling
the whole fungal cell surface proteins by membrane impermeable biotinylation reagent (87)
offered an alternative approach to differentiating surface proteins from cytosolic contaminants.
The labeled proteins can be enriched through avidin affinity chromatography followed by SDSPAGE separation. A typical cell membrane impermeable biotinylation reagent consists of two
moieties: a biotin group and a peptide reactive group. The peptide reactive moiety of
biotinylation reagents usually targets either the free amine groups (82)or free thiol groups (55) in
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protein/peptides. These labeling methods were successfully employed in the detection of Pir
(Protein with internal repeats) proteins in S. cerevisiae (51), Pir and Tsa1p in C. albicans (35)
(87). During avidin-biotin affinity purification of the labeled proteins/peptides, unlabeled
proteins/peptides may nonspecifically bind to avidin and eventually result in false identification.
This non-specific binding problem could be aggravated especially in the purification of heavily
glycosylated cell wall proteins.(49)

The accumulation level of C. albicans cell wall/surface proteins is highly dynamic and often
correlates with the extracellular environment. The dynamic change of cell wall/surface is
especially prominent during the conversion from yeast to hyphae of this pathogenic fungus.
Switching to hyphae is believed to be a necessary process for the pathogen’s penetration into
epithelia, endothelia and tissue as a result of the morphological adaptation of the fungal cell,
thereby contributing to its virulence in vivo (57). The morphogenesis is orchestrated by a wide
spectrum of complex signal network pathways under certain stimulus factors such as elevated
culture temperature at 37° C (29). Understanding the surface proteomic change of C. albicans
during morphogenesis is essential to the elucidation of fungal pathogenesis, thereby shedding
lights on the path of new drug target discovery. In previous studies, comparative 2D-PAGE
based approaches were employed to quantify the surface proteome change during a yeast to
hyphae conversion of C. albicans (66) (20). A small number (24) of proteins were found to be
differentially regulated before and after germination (20), probably due to the complicated
sample preparation procedure and the incompatibility of the gel-based method employed in the
cell wall protein separation. More recently, a comprehensive proteomic analysis of cytoplasmic
proteins and cell wall associated proteins from yeast cells, hyphae, and biofilms of C. albicans
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has been reported by Gil and co-workers(47). Compared to the conventional 2D-PAGE based
approaches, 2D-DIGE (2-D Fluorescence Difference Gel Electrophoresis) technique
significantly enhanced the capacity of protein quantification.(1) In addition to the 2D-PAGE
based comparative proteomic analysis, stable isotopic labeling techniques has more attractive
advantages such as good reproducibility, high accuracy and high throughput in protein
quantification (34). SILAC (61) is one of the important isotopic labeling methods and has been
successfully applied in various biological systems (74) (43) (88). The first step in SILAC method
is to metabolically label proteins through the incorporation of essential or nonessential amino
acids to living cells. Lysine is commonly chosen for its relative high abundance in proteins and
presence in the peptides produced by trypsin digestion. Relative quantification of protein can be
achieved by comparing the chromatographic peak areas of two paired peptides with the isotope
coded amino acid residues. Another advantage of the stable isotopic tagging is that it can be
introduced in vivo at early stages of cell growth; thereby variations due to sample preparation,
which were commonly observed in in vitro labeling, can be greatly reduced. One major
disadvantage inherent with the SILAC is that it can not be applied to microbes which do not
normally need any exogenous amino acids. Fungal cells (including C. albicans) are just one
such organism. Fortunately, this issue can be addressed through choosing a mutant strain which
is auxotrophic for certain amino acids such as lysine.(5)

In this study, the cell surface proteome of C. albicans was profiled by intact cell surface
biotinylation labeling technique coupled with LC-MS identification of surface exposed peptide
segments. Characteristic fragments originated from biotin tag moiety on tandem mass spectra of
peptide were employed to confirm that the peptides were labeled. Facilitated by the availability
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of a lysine production deficient mutant, the dynamic change of the surface proteome during
morphogenesis was quantified by using a SILAC based method which involved in an in vivo
stable isotope coded lysine labeling technique.

4.3 Experimentals
4.3.1 Yeast strains
C. albicans 6284 was the result of repairing strain BWP17 to prototrophy (69). It was a gracious
gift from Dr. G. Palmer (Louisiana State University Health Sciences Center, New Orleans, LA).
Strain CLD2 was obtained after sequential disruption of the LYS2 alleles and auxotrophic for
lysine (5). It was generously given as a gift from Dr. J. K. Bhattacharjee (Department of
Microbiology, Miami University, Oxford, OH).

4.3.2 Cell surface labeling with biotinylation reagents
C. albicans 6284 were cultured on YPD plate (Becton, Dickinson and Company, Franklin Lakes,
NJ) at 37 ° C for 2 days. Cells were slightly scratched off the medium using sterilized pipette
into 1.5 mL centrifuge tube and consequently washed by ice-cold phosphate-buffered saline PBS
pH 7.4, five times with final OD600=2.7-2.8 in 1mL PBS 7.4. Biotin labeling reagent (sulfoNHS-LC-biotin or sulfo-NHS-SS-biotin or iodoacetyl-PEO2-biotin) (Pierce, Rockford, IL) (14
mM) in 300 ul of ice cold PBS 8.0 was added to the washed cells. After a short vortexing to form
a cell suspension, the mixture was incubated at 4°C with 400 rpm mixing in a cold room for 2
hours. When iodoacetyl-PEO2-biotin reagent was used, intact yeast cells were initially treated
by 10 mM tris-(2-carboxyethyl) phosphine (TCEP) (Promega, Madison, WI) at 4°C for 20
minutes prior to the incubation step, and the cells were washed again by PBS 7.4 3~5 times
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before the labeling. The labeling reaction was quenched by adding ice cold 1 mL of 50 mM TrisHCl (pH 8.0) and by further incubation at 10°C for 15 minutes. Finally the labeled cells were
extensively washed by ice cold PBS buffer (pH 7.4) to remove by-products of the biotinylating
labeling reaction.

4.3.3 Tryptic digestion of intact cells (“whole cell shaving”) and peptides extraction
Yeast cells labeled with sulfo-NHS-LC-biotin or iodoacetyl-PEO2-biotin were first washed by 1
mL of 50% methanol two times and suspended in 500 µL 50 mM ammonium bicarbonate. To
this suspension of yeast cells, 15 µl of 200 mM dithiothreitol (DTT),(Sigma, St. Louis, MO) was
added followed by 40 minutes incubation at room temperature. 7 µL of 1 M iodoacetamide (IA)
(Sigma, St. Louis, MO) was added to the cell suspension followed by an additional 40 minutes
incubation at room temperature. After centrifugation, cell pellets were washed by 500 µL of 50
mM ammonium bicarbonate three times. Finally, 8 µg trypsin in 40 µL of 50 mM ammonium
bicarbonate was added to the cell pellet followed by a brief vortexing. The trypsin digestion was
carried out at 37°C for 18 h. For sulfo-NHS-SS-biotin labeled cells, washing the cells with 60%
MeOH was conducted instead of dithiothreitol/iodoacetamide (DTT/IA) treatment before trypsin
digestion.

The digestion was stopped by freezing the sample in liquid nitrogen. Supernatant containing
soluble peptides were collected. More tryptic peptides were subsequently extracted by acidic
water (5% formic acid), 10% ACN, 30%ACN and 50% ACN. Extracts were combined and then
evaporated to dryness in vacuum.
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4.3.4 Affinity enrichment of biotinylated peptides
Extracted peptides after “whole cell shaving” were first purified using ICAT-cartridge-cation
exchange column (Applied Biosystems, Foster City, CA) to remove DTT, IA and trypsin.
Peptides labeled by non-cleavable reagent were enriched on cartridge-avidin column according
to the protocol provided with the ICAT reagent kit (Applied Biosystems, Foster City, CA). After
vacuum drying at room temperature, the labeled peptides were dissolved in 3% ACN containing
1% formic acid for LC-MS/MS analysis.
Sulfo-NHS-SS-biotin labeled peptides were incubated in 0.2 mL neutravidin beads (Pierce,
Rockford, IL) in 200 µl binding buffer (2×PBS pH 7.2) at room temperature for 1 hour with
mixing. After centrifuge, supernatant was discarded and the beads were washed three times by 2
mL of PBS (pH 7.2), 2 mL of PBS ( pH 7.2 ) containing 1% Triton X-100, 2 mL of 50 mM
ammonium bicarbonate in 20% MeOH and finally 2 mL of H2O. The beads were incubated in
250µL of 20 mM TCEP at room temperature for 30 minutes to release the labeled peptides. The
reduction and extraction process were repeated two times followed by additional four times
washing of the bead with 5% ACN. All extracts and washes were combined and vacuum dried
before LC MS/MS analysis.

4.3.5 In vivo isotopic lysine labeling during germination growth of yeast
Lys2- auxotroph strain (C. albicans CLD2) cells (5) were first streaked on a YPD ((1% yeast
extract, 2% bacto peptone, 2% glucose) plate and incubated for 3 days at room temperature. A
single colony was then selected and resuspended in 5 mL of liquid YPD medium in a centrifuge
tube for pre-culturing at 25°C for 10 hours. These cultures were inoculated in 100 mL of YPD
with a dilution of 1:200 and grown under 25°C for 36 hours as yeast cells. Cells were harvested
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by centrifugation under 4°C and extensively washed by cold PBS buffer (pH 7.4). Cells were
subsequently inoculated at 8x106 /cells in 100 mL SILAC DMEM (minus lysine and arginine)
(Pierce, Rockford, IL) which had been supplemented by isotopic labeled lysine (K*.2HCl, 180
mg/L) (Cambridge Isoptope Laboratories, Andover, MA), arginine (R.HCl, not isotopic labeled,
84 mg/L) (Sigma, St. Louis, MO) and HEPES (5.958 g/L) (EMD Chemicals Inc., Gibbstown,
NJ). After 2 hours of germination at 37 °C hyphae cells were then harvest by centrifugation
under 4°C and repeatedly washed by cold PBS buffer (pH=7.4).

4.3.6 Extraction cell wall proteins by SDS-DTT
A cell wall fraction was prepared according to procedures described previously with some
modifications (66). Briefly, hyphae cells were washed 3 times by ice cold lysis buffer (10 mM
Tris-HCl, pH 7.4, 1 mM phenylmethylsulfonyl fluoride, PMSF), resuspended in cold lysis buffer
and transferred in screw capping vials which contained equal volume of glass beads (425-600
µm in diameter, acid washed). The cells were mechanically broken with the glass beads in a dry
ice precooled bead mill cell homogenizer at the maximum speed for 45s for 7 cycles with
intermittent cooling on ice immediately after each cycle in a cold room (4°C). The complete cell
breakage was confirmed by microscopic examination and failure of cell growth in YPDchloramphenicol (10 µg/mL) plates. Glass beads were filtered out through a sponge packed 10
mL syringe and washed by cold lysis buffer untill the washing solution was clear. Crude cell
wall pellet was separated from of soluble cytosolic fraction after centrifugation at 2000 g for 10
minutes at 4°C. The collected cell wall fraction was washed and vortexed in 10 mL of cold 1mM
PMSF solution for 3 times. The wall pellet was subjected to extensive washing and vortexing by
a gradient of cold 10 mL NaCl solution (5%, 2%, 1% in 1mM PMSF) for 5 times each. The
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pellet was finally washed by another 10 mL of cold 1 mM PMSF again. The washed cell wall
fraction was boiled in 300 ul of SDS extraction buffer (2% SDS, 0.1 M EDTA, 15 mM freshly
made DTT, 50 mM Tris-HCl, pH 8.0) for 4 times of 10 minutes. The supernatants were
combined for the first three extractions after centrifugation at 1000 g for 10 minutes and the 4th
extract was discarded. SDS extracted proteins were immediately carboxyamidomethylated with
500 mM iodoacetamide (4 fold mole excessive to DTT in the extracts) at room temperature for 1
hour in the dark. SDS extracted proteins were precipitated by CHCl3/MeOH (90). The protein
pellet (SDS-DTT extracted cell wall protein) was stored at -80°C for future use.

4.3.7 SDS-gel electrophoresis (PAGE) and in-gel digestion
The protein pellet from SDS extraction was suspended in 1% SDS and heated at 90°C for 2
minutes. After a brief vortexing to solubilize the pellet, protein concentration was determined by
BCA. Protein samples (three biological replicates, 100 µg for each sample) were loaded onto
each well of a mini-gel, separated by SDS-PAGE 9% acrylamide gels and stained by Coomassie
blue. Stained bands for each sample were excised and in-gel digested as previously described
(71).

4.3.8 LC-MS/MS analysis and database search
LC-ESI MS/MS was performed on Finnigan LTQTM-ion trap mass spectrometer
(ThermoFinnigan, San Jose, CA) coupled with a Finnigan Micro Auto Sampler. Vacuumconcentrated samples (not completely dried) were suspended in 25 µL of 5% acetonitrile and 5%
formic acid in a ninety six well micro plate and the volume for each sample injection was 8 µL.
The sample mixture was first loaded to a C18 trap column and washed with 3% acetonitrile and
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0.1% formic acid for 60 minutes for desalting, then the purified peptides were eluted to a
reverse-phase C18 analytical column by a 60 minutes gradient made of A buffer (0.1% formic
acid: 97% water:3% acetonitrile v/v/v) and B buffer (0.1% formic acid: 3% acetonitrile: 97%
water v/v/v) at a flow rate of 200 ~ 500 nL/min. Separated peptides were analyzed under the
data-dependent acquisition mode set by Xcalibur, 2.2 version (Thermo Electron). After a MS
survey scan over the m/z range of 300-2000, seven (three for samples from SILAC labeling
experiments) most intensive precursors were selected and subjected to fragmentation by CID
(collision induced dissociation). The normalized collision energy was set at 35% with activation
Q value being 0.25 and dynamic exclusion of 100 seconds. The acquired raw data were
processed by BioWorks software, version 3.3 (Thermo Electron) and tandem mass spectra were
searched against a C. albicans protein database (downloaded from NCBI) by using SEQUEST
algorithm.

Parameters for SEQUEST database search were set as follows: differential mass increase of
414.19 Da on cysteinyl (for iodoacetyl-PEO2-biotin labeling), 340.1 Da on lysine residue (for
sulfo-NHS-LC-biotin labeling), 88.01 Da on lysine residue (for sulfo-NHS-SS-biotin labeling)
and 8.00 Da (for SILAC labeling) in addition to 57.02 Da on cysteinyl and 15.99 Da on
methionine residue. The number of missed cleavage sites was set to three. The output for the
search results was filtered by cross-correlation score (XCorr) which must be ≥ 3.0 for the triply
charged ions, ≥ 2.5 for the doubly charged ions and ≥ 2.0 for the singly charged ions. Also, delta
correlation score (∆Cn) was set to be ≥ 0.1. MS/MS spectra of all the biotinylated modified
peptides were manually inspected to ensure the quality of spectra. “Pepquan” tool in BioWork
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3.3 was used for SILAC protein quantification. Chromatographic peak areas of peptide pairs
were manually inspected or adjusted to ensure accurate quantification.

4.4 Results and Discussion
4.4.1 Surface protein profiling by three biotinylating reagents and LC-MS
The intact yeast form of C. albicans 6284 was labeled with three membrane impermeable
biotinylation reagents respectively at low temperature. These labeling reagents were routinely
used in cell surface biotinylation method (23) as a procedure to reduce possible cytosolic
contamination in the cell membrane protein fraction (21). Sulfo-NHS-LC-biotin and sulfo-NHSSS-biotin target free amine groups in the side chain of lysine residue and unmodified N-termini
of proteins, while iodoacetyl-PEO2-biotin reacts with cysteine residues. To maximize the
sequence coverage, confirm the labeling and test the efficiency of those reagents in the
bitotinylation of C. albicans cell surface proteins, all three labeling reagents were employed. In
order to reduce the potential cell response to the labeling reactions, the labeling procedures were
conducted at low temperature (4°C) in PBS (8.0) buffer. Urban’s group also confirmed the
efficacy of the labeling and membrane impermeability of sulfo-NHS-LC-biotin by using
colloidal gold immunoassay (87).

Unlike other methods in which cell wall fractions were prepared from cell lysate or biotinylated
proteins were enriched after the labeling process, the “whole cell-shaving” method employed in
our experiments yielded labeled peptides by trypsin digestion of the intact fungal cells. The
“shaving” technique had been previously utilized to identify bacterial surface proteins for
vaccine candidates search (70). We employed this technique with an aim to preferentially cleave

118

surface proteins mostly exposed to the extracellular environment. Also, membrane proteins (such
as GPI anchored proteins) are likely to be shielded by outer cell wall proteins and partial trypsin
digestion of these proteins was expected. However, this “whole cell shaving” technique could
not totally eliminate cytosolic contamination, as the DTT/IA treatment of the whole fungal cell
might damage the plasma membrane and lead to leakage of cytosolic proteins (36). Avidin
affinity chromatography allowed us to enrich biotinylated peptides from a highly complex
mixture of peptides, but the enriched biotinalyted peptide fraction may still contain digested
cytosolic proteins. Fortunately LC-MS and bioinformatic analyses of enriched biotinalyted
peptide fraction would provide unambiguous information as to which peptide was biotinalyted,
and thus determine the cell wall/surface location of the protein from which the biotinayated
peptide was derived.

LC-MS analysis yielded tandem mass spectra of peptides in the enriched biotinalyted peptide
fraction. Database searches were subsequently performed on the peptide tandem mass spectra by
using SEQUEST algorithms. Once a tandem mass spectrum was determined to match a peptide
sequence, the search result would also include information on which amino acid residue (s) was
(were) modified by the labeling reagent defined prior database search. Moreover, characteristic
fragments originated from the labeling reagent further confirmed that the peptide was labeled.
Figure 4.1B is a tandem mass spectrum of peptide ion at m/z: (the precursor ion was detected in
MS spectrum as shown in Figure 4.1A). The b ions and y ions in the spectrum provided
information about the sequence of the peptide as well as which amino acid residue was modified
by the labeling reagent (sulfo-NHS-LC-biotin). Two fragment ions at m/z 340.2 and m/z 227.1
were originated from the sulfo-NHS-LC-biotin tag (see Figure 4.1C). As for iodoacetyl-PEO2-
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biotin labeled peptides, characteristic fragment ions at (m/z): 449.1, 375.2, 332.2 and 270.1
corresponding to the cleavage sites as shown in Figure 4.2 could also be observed for the
biotinylated peptides upon CID. These fragment ions originated from iodoacetyl-PEO2-biotin tag
were comprehensively studied previously (7).

Even though sulfo-NHS-SS-biotin labeled peptides do not yield characteristic fragments that can
be retrieved to the labeling reagent, the tandem mass spectra of the labeled peptides contains
enough information for the sequence and modification site(s) determination (data not shown). It
should be noted that biotinylated peptides determined in the above mentioned experiments not
only confirmed the cell surface localization of the proteins from which they were derived, but
also represented the peptide segments of these surface/surface affiliated proteins that were likely
exposed outside to the extracellular environment. For instance, several biotinylated peptides
were detected for CaPMA1 plasma membrane H+-transporting ATPase (CA 2300). The detected
peptides ( Figure 4.3 (A)) were located in the hydrophilic loops that were likely exposed to the
outside as predicted by TopPred (http://bioweb.pasteur.fr/seqanal/interfaces/toppred.html)
(Figure 4.3 (B) ), rather than in the more hydrophobic parts that might be buried in the cell wall
or cell membrane.
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Figure 4.1. An example of LC-MS analysis of enriched peptide released from C. albicans cells
labeled by sulfo-NHS-LC-biotin. (A) Precursor ion 620.31 (m/z) was selected for MS/MS
experiment. (B) The MS/MS spectrum for the precursor ion 620.31 (m/z). The “b” and “y” ions
are labeled together with the two biotin moiety specific ions of 227.1 (m/z), 340.2 (m/z). The
peptide was identified by SEQUEST as VPK@SLLDK (K@, modified lysine residue). (C) Two
characteristic fragment ions produced upon CID from the biotin moiety attached to a lysine
residue
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Figure 4.2. MS/MS spectrum of an iodoacetyl-PEO2-biotin labeled peptide matched the
sequence of VILC#GEETLEER as a result of SEQUEST search. Four tag specific ions at m/z:
270.1, 332.2, 375.2, and 449.1 can be observed.
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Figure 4.3. (A) Part of amino acids sequences of CaPMA1 plasma membrane H+-transporting
ATPase and peptides detected by labeling using sulfo-NHS-SS-biotin (highlighted in dark red),
iodoacetyl-PEO2-biotin (highlighted in blue) and Sulfo-NHS-LC-biotin (highlighted in green)
respectively (B) Topology of CaPMA1 predicted by TopPred from
(http://bioweb.pasteur.fr/seqanal/interfaces/toppred.html). Lines colored in brown and blue
corresponding to the peptides in the same color shown in (A).
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4.4.2 Cell wall proteins identified based on the detection of biotinylated peptides
Based on this approach, LC-MS analysis of biotin-avidin affinity enriched tryptic peptides
resulted in the identification of more than 200 proteins. The experiments included: 1. whole cell
labeling by sulfo-NHS-LC-biotin or sulfo-NHS-SS-biotin or iodoacetyl-PEO2-biotin; 2. trypsin
digestions of the labeled whole cell to release peptides; 3. biotin-avidin enrichment of the
biotinylated peptides; 4. LC-MS/bioinformatic analyses of the biotinylated peptide enriched
fraction. Among these 200 plus proteins, one hundred and fourty eight cell wall proteins
(supplemental Table S1) were assigned based on the detection of multiple biotinylated peptides
(see Table 4.1 for examples). If protein identification was based on three or less peptides, the
tandem mass spectra of the peptides were manually inspected for biotin tag specific ions to
verify the identification. This study, to our knowledge, is the most accurate profile of cell surface
proteome of C. albicans, because the identification of proteins was based on the detection of
labeled peptides, and in some cases was further confirmed by the characteristic fragment ions
originated from the biotinylation labeling reagent. In our experiments, fifty one proteins were
identified as cell wall proteins for the first time (highlighted in green in supplemental Table S1).
Among these fifty one identified proteins, twenty seven were identified by only one biotinylated
peptide, possibly due to the low abundance of these proteins. Even though these twenty seven
proteins had never been reported as cell wall proteins, their cell wall/surface localization could
be confidently assigned based on the unambiguous detection of biotinylation labeling reagent
modified peptide, i.e. detection of the exposed peptide segment of this protein.
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Table 4.1. A short list of 5 examples of identified cell surface proteins of C. albicans strain 6284
based on detection of biotinylated peptide(s) by LC-MS

Note: The accession numbers are adopted from Candida DB
(http://genodb.pasteur.fr/CandidaDB). K&: lysine residue modified by sulfo-NHS-LC-biotin;
K#: lysine residue modified by sulfo-NHS-SS-LC-biotin; C@: cysteine residue modified by
iodoacetyl-PEO2-biotin
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Three biotinylation reagents, sulfo-NHS-LC-biotin, sulfo-NHS-SS-biotin, and iodoacetyl-PEO2biotin, were employed in three similar approaches to identify cell wall/surface proteins of C.
albicans. Each approach has unique protein identifications, and there were also protein
identifications shared by different approaches (Figure 4.4) (supplemental Table S1). Twenty
proteins (GAP1 TEF1, SSA4, FBA1, PDC11, PGK1, EFT2, TPI1, MET6, PET9, RPL3, SSB1,
SAH1, HXK2.3f, ACH1, CHT2, RPL82, ATP2, IPF2431, PMA1) were detected in all the three
approaches, which implies that these proteins may have relative high abundance in the cell
wall/surface. The repetitive detection of these proteins also confirmed their cell wall localization
and the corroborative nature of the three approaches. Surprisingly, ACH1, SAH1 were never
reported in literature as cell wall proteins even though they could be regarded as abundant
proteins in our study. It seems that these proteins may also have known cytosolic functions such
as acetyl-CoA hydrolase activity (for ACH1) and adenosylhomocysteinase activity (for SAH1),
but their roles in cell wall remain unknown. These two proteins may be regarded as secreted
proteins since they were both detected in the serum from patients under systemic candidiasis
(64). SAH1 may also contribute to the biofilm formation of C. albicans and act as an adhesion
molecule to host (25). ENO1 was identified as one of the most abundant cell wall proteins in our
study with the detection of twenty eight peptides labeled by sulfo-NHS-LC-biotin or sulfo-NHSSS-biotin (but not by iodoacetyl-PEO2-biotin because it has no cysteine residue in its sequence).
It was also previously identified as a major cell wall glycolytic enzyme located in the inner
layers of the glucan wall matrix via monoclonal antibody probing and immunoelectron
microscopy(3), and this protein might be account for 0.7 and 2% of the total protein in both
yeast and hyphae cells (83). Edwards group (21) first detected the presence of Enolase in the
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Figure 4.4. Pie graphic representation of detected cell wall proteins biotinylated by three
labeling reagents. 95 proteins were detected via labeling by sulfo-NHS-SS-biotin (dark red), 69
by iodoacetyl-PEO2-biotin (in blue) and 79 by sulfo-NHS-LC-biotin (in green).

127

cell wall of S. cerevisiae, which prompted them to propose an alternative secretion pathways for
proteins without signal sequences. Other proteins (labeled by all three labeling reagents), such as
FBA1, MET6, PGK1, SSB1, TEF1, TPI1 and TSA1 are mainly involved in pathogen- host
interactions. FBA1, MET6, PGK1, SSB1, and TPI1 showed immunogenecity in a murine model
and could be induced by symbiote of host defense response (65). Interestingly, ribosomal
proteins (RPL3 and RPL82) and translational elongation factors (EFT2 and TEF1) were also
detected as abundant cell wall proteins. Although their functions at cell wall were unknown, they
had been shown to be highly antigenic both in mouse and human (48)

The largest overlapping proteins were detected by both of the two approaches that involved in
sulfo-NHS-LC-biotin and sulfo-NHS-SS-biotin. These thirty eight cell wall proteins include
ENO1, ADH1, ECM33.3, RPL2.3, RPL17B, RPS15.3, CIT1, RPL18, RPL19A.3, GAD1,
RPS31, RPL23B.3, RPL7A.3, IPF8762, PRA1, RPL28.3f, IPF14171, RPS4, KAR2, HHF21,
RPS3, PGI1, ICL1, POT14, SSC1, HTA1, RPL10, RPL32, HSP70, RPL6.3, IPF9926, RPS22A,
HTB1, EFB1, ACT1, ADK1, RPS19A.3, AMYG1. This large overlapped detection was because
that both labeling reagents targeted the same functional group (amine) in cell wall proteins.
Interestingly, for the same protein detected by both approaches, each approach detected different
regions. For example, sulfo-NHS-LC-biotin detected K&NPROFGLLVALDAEGTASGK (&
indicates the biotinylation site) while sulfo-NHS-SS-biotin labeled
K+NPFGLLVALDAEGTASGK (+ shows the biotinylation site), although both labeling
reagents identified the same protein AMYG1. Since the cells were labeled under the same
conditions, the difference in the detection of labeled peptides could be due to the peptide elution
process during affinity enrichment. The sulfo-NHS-SS-biotin labeled peptides were released
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from the avidin column via the reductive cleavage of the disulfide bond, and the released peptide
has a smaller tag than sulfo-NHS-LC-biotin labeled peptides.

The overlapped detection shared by approaches involved with sulfo-NHS-SS-biotin and
iodoacetyl-PEO2-biotin includes seventeen proteins (PCK1, MLS1, CDC19, PDA1, GND1,
CEF3, GPH1, CAR2, GCV2, ADH2, RPS23, IPF17186, RPL10A, ZWF1, ACO1, RPL12,
IDH2). These two labeling reagents target different functional groups. Similarly, the overlapped
detection shared by sulfo-NHS-LC-biotin approach and iodoacetyl-PEO2-biotin approach include
six proteins (RPS10, SRB1, RPS6A, NCP1, PHR2, RPL4B). It should be noted that large set of
proteins were detected in each approach (ATP1, GPM1, QCR2, IFD4, TAL1, RPL13, LPD1,
IPF9803, TKL1, IDH1.3, VMA4, GCV1, RBT5, HHT21, CDC48, AMS1, IPF11299, HSP90,
HHT3, KRS1, FDH11.3, IPF3358 in sulfo-NHS-SS-biotin labeling approach; ALD5, IPP1,
HSP60, MIS11, MDH1, FAS2.5f, SCW1, SAC6.5f, HEM13, ADO1, CHC1, RIB3, ARO4,
IPF11123, YNK1, AAT1, FBP1, ADE6, MNT1, ARA1, CPR3, VMA2, IPF6629, ADE17,
IPF9550, BMH2, IPF470, TRX1 in iodoacetyl-PEO2-biotin labeling approach, and ALS4.5f,
CYP1, UCF1, IMH3, BGL21, IPF17237, PDI1, ADH5, MCR1, GSP1, ATP4, FUM12.5f,
IPF11888, KES1, SOD21, ACC1, NTF2 in sulfo-NHS-LC-biotin labeling). Sulfo-NHS-SSbiotin had been chosen by other investigators (63) to reduce possible intracellular labeling since
the reductive cytosolic milieu would potentially cleave the disulfide bond in the labeling reagent,
(6) therefore affect the enrichment of labeled cytosolic proteins. Contrary to this theory, we
found that the sulfo-NHS-SS-biotin labeling approach detected the largest number of proteins,
and it might imply that proteins detected by biotinylation were not related to the cytosol.
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4.4.3 Localization of identified putative cell wall proteins
All identified cell wall proteins were analyzed by Gene Ontology (GO) (8) (4) Slim Mapper at
CGD (http://www.candidagenome.org/cgi-bin/GO/goTermMapper) with a filter set for
“annotations from High-throughput Experiments” and “the Manually Curated”. As shown in
Figure 4.5, 55.8% of the identified proteins have been fully annotated. Majority of the annotated
proteins were cell wall (25.9%), plasma membrane (20.4%), membrane associated (7.5%) and
extra cellular region (4.8%) proteins. This result demonstrated that biotinylating reagents were
selective in labeling cell wall/membrane proteins. BGL2 was a classical yeast form cell wall
protein of C.albicans which had been confirmed to have cell surface location (33, 66) (12). It
should be noted that many proteins identified in our study might have multi-locations. For
example, ENO1 was classified in six locations (cell wall, membrane, plasma membrane,
cytoplasm, membrane fraction and extracellular region). ADH1, ENO1, HSP70, HSP90, and
PGK1 from cell wall fraction were also assigned as cytosolic proteins (5 out of 19). It is quite
common in microbes that proteins may have multiple localizations, and a term “moon-lighting”
was coined for those proteins with an emphasis for their second function in the cell wall. Also, a
new mechanism (59) of protein exporting had been proposed for cell wall proteins that lacked an
N-terminal signal sequence for secretion. An increasing number of proteins without N-terminal
signal peptide had been found in both S. cerevisiae and C. albicans and were compared in a
recent review (59). Detection of conventional cytosolic proteins in this study is consistent with
previous reports in which the surface presence of highly abundant proteins (GAP1, FBA1,
PDC11, TPi1p, ADH1, PGK1, GPM1) involved in glycolysis were confirmed. For instance,
GAP1 protein was previously detected as cell surface antigen through indirect
immunofluoresence (26). Moreover, work by Cutler’s group (91) demonstrated that glycopeptide
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vaccines containing peptide moieties from FBA1, ENO1 and GAP1 could induce protection
against candidiasis in a murine model. An elegant study had been done to confirm that PGK
protein was present in the cell wall by several approaches (2). Similarly, FBA1, PDC11, GPM1
and TPi1p were detected in cell wall fractions by using 2D-gel based proteomic method (47) (20)
(66). Heat shock protein like SSA1 and HSP60 had also been previously detected as cell wall
proteins both in C. albicans (40) and S. cerevisiae (40). HSP90 (or its fragments) was isolated as
a major antigen from the body fluids of patients
with disseminated candidiasis (50), suggesting that it might be also a secreted protein. For these
proteins with multiple cellular localizations, their functions in the cell wall were believed to be
unrelated to their well known cytosolic functions. ADH1 was also proven to be critical in biofilm
formation on catheter surfaces (53) and recently its existence on the cell surface was confirmed
by a biotinylation technique (87). The high abundance of glycolytic enzymes in cell wall may be
relevant to their roles in C. albicans pathogenesis. Previous studies indicated that those proteins
were highly immunogenic in inducing host immune responses. (26) (32) (86) (75). Much
attention has been drawn to these glycolytic enzymes in vaccine development regarding their
function in stimulating immune response of host cells. ENO1 was viewed as an immunodominant antigen as other conventional cytosolic proteins such as elongation factors and
glycolytic enzymes in literature. For instance, one of the three cytosolic proteins (ACH1, ICL1,
MLS1) identified in our study, ACH1 was well known for converting acetyl-Co A to/from
acetate in cytosol , and its possible cell wall location has never been determined previously.
However, ACH1(64)was detected in the serum specimens of candidiasis patients and showed
high immunogenicity. Interestingly, work by Lorenz group (11) showed that a mutant strain
lacking ACH1 is still fully virulent in a murine model.
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Figure 4.5. Component classification of identified cell wall proteins based on GO Slim Mapper
at CGD. The classification was based on annotation type selections for High-throughput
Experiments and Manually Curated (the same for process classification in Figure 4.6). Out
called figures represent the percentage of the number of classified proteins at the corresponding
component over the total annotated proteins. The same proteins may be classified into two or
more components.
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MLS is an active enzyme in glyoxylate cycle which is required for wild-type virulence in murine
systemic infection (41).

Proteins normally observed in ribosomes were also found in our study. Many of these proteins
like RPL10, RPL10A, RPL12, RPL13, RPL18, RPL19A, RPL23A, RPL32, RPL82, RPS10, can
not be mapped by GO program at GCD due to no annotation for the specified GO Slim term in
the selected annotation set. Therefore the real functions of these “ribosomal” proteins in cell wall
need to be studied further in future. Other investigators also detected some ribosomal proteins
(RPS4B, RPL3, RP10, RPL3 60S, RPL20B, RPP0) in cell wall pellet fraction (20) of both yeast
and hyphal forms; however possible cytosolic contaminations as a result of low speed
centrifuging during cell wall pellet fractionation could not be ruled out. On the contrary, results
from another group (66) did not include any ribosomal proteins even though the same cell wall
preparation method and gel analysis were employed. It is possible that the “ribosomal” proteins
may adventitiously bind to the cell wall after they escaped from the broken dead cells and react
with the labeling reagents as discussed above. Although this possibility can not be totally ruled
out, the extensive labeling of those “ribosomal” proteins suggests their localization on the cell
surface. Additionally, RPL20B, RPP0, RPL3 60S, RP10 ribosomal proteins were also detected in
the SDS-DTT resistant cell wall fraction(20), which should be free of any non-covalently
associated proteins (including cytosolic proteins stuck to the plasma membrane or wall matrix)
after extensive hot SDS washings. Therefore, these “ribosomal” proteins may be regarded as cell
wall proteins rather than cytosolic contaminations. Study has shown that RP10 was
immunogenic in human infection of C. albicans. (86) In Neisseria gonorrhoeae, RP L12 was
believed to play an important role in invasion of human reproductive cells and shown to be
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associated with the plasma membrane and exposed to the cell surface (81). Immunochemical
assays would be needed to confirm the cell surface localization of any protein of interest
identified in this study.

A group of elongation factor proteins (TEF1, EFT2, CEF3,EFB1) was identified in our study as
well, which was consistent with reports from other investigators (20) (66). Interestingly, these
proteins were reported to be absent on the cell wall of S. cerevisiae. Detection of these
elongation factors have also been reported as extracellular or cell envelope associated protein in
microbes such as C. albicans (44), Trichoderma.reesei (39) and Staphylococcus aureus (76).
Moreover, the presence of TEF1 in tobacco cell walls has been confirmed by immunogold SEM
analysis (94). Localization of TEF1 on the cell surface of C. albicans could also be supported by
its ability to bind plasminogen (17). The cytosolic functions of these proteins are related to
protein synthesis and interactions with other proteins, but their roles on the cell wall are largely
unknown. Although the approaches employed in our study minimized the possibility of cytosolic
contamination, these possibilities still could not be ruled out: 1. Labeling reagents might react
with those highly abundant cytosolic proteins in aging or non-viable cells whose disintegrating
plasma membranes could not serve as barriers for the biotinylating reagents. 2. Certain channels
(like Na+ ion channel) in plasma membrane could potentially uptake the sulfo-NHS-LC-biotin
and sulfo-NHS-SS-biotin labeling reagents. Some researchers intended to accept the fact that
these “ribosomal” proteins could indeed present in the cell wall possibly through the noncanonical secretion pathways as mentioned earlier (59). Also, a series of histone-like proteins
(HHT21, HHT3, HHF21, HTA1, HTB1) were detected in our study. Antigenic histone H2B-like
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cell surface protein was also confirmed in Histoplasma capsulatum and predicted to be a new
candidate antigen in vaccine development (60).

4.4.4 Identified putative cell wall proteins classified into different cellular processes by GO
(8) (4)
The different roles of the identified proteins are summarized in Figure 4.6. The majority of
proteins involved in the processes of interspecies interaction between organisms (17.7%),
interaction with host (12.9%), carbohydrate metabolic process (8.8%), filamentous
growth (8.2%) and pathogenesis (6.8%). Other proteins are mainly associated with other
important biological processes such as hyphal growth, biofilm formation, cell wall organization
and cell adhesion. Identification of proteins involved in the processes related to pathogen’s
interaction with the host and other organisms suggests that those proteins are exposed to the
extracellular environment and serve as initial points to interact with the host cells (e.g. adhesion,
biofilm formation and recognition). Interspecies interaction between organisms generally
includes interaction with hosts (HSP70, ADH1, PGK1, GPM1 and FBA) and symbiosis
(encompassing mutualism through parasitism), which consists the response to defenses of other
organism (through evasion or tolerance of defenses of other organism, MNT1), pathogenesis
(CSH1, ECM33, PHR2, HSP90, BGL2, MNT1, ICL1, LPD1, MP65, BMH1), modification of
morphology or physiology of other organism ( through induction by symbiont of host defense
response, SSB1, HSP70, ACO1, TPI1, ADH1, MET6, CDC19, ENO1, PGK1, MP65, FBA1),
adhesion to other organism (through adhesion to host, BGL2, PRA) and movement in
environment of other organisms (through entry to host, ENO1). Also 21 (CSH1, SSB1, HSP70,
ECM33, PHR2, HSP90, ALS4, TEF1, BGL2, PRA1, TPI1, ADH1, TSA1, MET6, CDC19,
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Figure 4.6. Process classification of identified cell wall proteins based on GO Slim Mapper at
CGD. Outcalled figures represent the percentage of the number of classified proteins involved in
the corresponding process among the total annotated proteins. Same proteins may be classified
into different processes.
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ENO1, PGK1, GPM1, MP65, BMH1, FBA1) out of 26 proteins associated with interactions with
organisms have been previously detected in the cell wall. It also should be noted that it is
common that one protein can be found in different biological processes. For example, CSH1
plays roles in pathogenesis (77), biofilm formation (58), and cell adhesion (78). ADH1 was
classified into processes such as carbohydrate metabolism (85), generation of precursor
metabolites and energy and biofilm formation (53) in addition to its involvement in the
interaction with the host (17). MNT1 (54) was involved in interacting with the host (9), cell wall
organization, filamentous growth and cell wall mannoprotein biosynthetic process. In addition to
their roles in various interaction processes, ADH1, CDC19, ENO1, FBA1, GPM1, PGK1, TPI1,
TSA1 are also involved in carbohydrate metabolic process (13). BGL2, BMH1, CSH1, ECM33,
HSP90, ICL1, LPD1, MNT1, MP65, PHR2 were assigned as cell wall proteins that play
important roles in C. albicans pathogenesis. MP65 was extensively studied for its capability to
induce immune responses in humans (27, 28). ADH, FBA1, PGK1, TEF1, GMP1, TSA1 were
among the eight cell wall proteins which had been shown to have the capability of binding to
human plasminogen (17, 67). Recent work by Cutler and co-workers (91) demonstrated that
peptide segments from FBA1, ENO1, GAP1, MET6, PGK1 could be conjugated to β-mannan
trisaccharide [β-(Man)3] to produce novel glycopeptide vaccines against candidiasis in mice. The
high effectiveness of protection induced by β-(Man)3-FBA1 and β-(Man)3-MET6 suggested that
FBA1 and MET6 may be potent immunological proteins presented at the cell surface of C.
albicans. Thirteen proteins are associated with the second largest process-carbohydrate
metabolic process (based on their cytosolic functions): SRB1 in GDP-mannose biosynthesis;
ENO1, PGK1,GPM1 and PCK1 in gluconeogenesis; ADH1,CDC19, ENO1, PGK1, GPM1 in
glycolysis; MLS1, ICL1 in glyoxylate cycle; MNT1 in N-glycan processing; SRB1 in protein
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amino acid glycosylation; MNT1 in protein amino acid O-linked glycosylation and MP65 in
cellular glucan metabolism. Again, new cell wall functions of those well known cytosolic
proteins have been being discovered and showed to be different from their primary roles in the
carbohydrate metabolic pathway (59).

Heat shock protein and chaperon proteins (HSP90, HSP70, HSP60, SSA1, SSA4, SSB1, SSC1,
KAR2) are well known for their function to repair damaged proteins as a result of certain stress
to the cell (e.g. drugs, heat and toxins) (37) (89), to maintain the integrity of the cell (42), and for
their high immunogenicity in inducing host immune response in C. albicans pathogenesis. (46)
Classification of those proteins indicated that also play other roles in other complicated
biological processes. For example, HSP70, HSP90 and SSB1 were all classified as proteins
interacting with host for their roles in response to the ligands released by other organisms.
Additionally, HSP70 was identified as a cell envelope binding protein for human salivary histatin
5 (38). Interestingly, HSP70 led to enhanced systemic candidasis in murine model due to its high
immunogenicity. (10) Moreover, HSP70 proteins are also involved in many facets of proteins
regulation including their folding and trafficking across the membrane (16). Also, Work by Piper
(62) and Nombela’s (65) group suggested that HSP90 was responsive to pheromone in C.
albicans infections and SSB1 was an immunoreactive protein in murine model, which indicated
that these proteins somehow interacted with the host. Interestingly, the OG didn’t classify any
heat shock proteins into cell adhesion process while HSP70 family proteins were viewed as
major adhesins in a recent review article (13). Notably, for the first time we detected the Dnaktype molecular chaperone (CA 0915), which was encoded by a gene about 50% identical to all
eukaryotic HSP70s. However, very little information of this HSP can be found in literature. The
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low abundance of this protein in the cell wall might be the main reason that it had never been
detected before.

Proteins involved in cell adhesion process also attract much attention from investigators who
want to gain better understanding on the mechanism of the host-pathogen interactions. Proteins
ALS4 (19), CSH1 (54, 78), MNT1 (54), MP65 (72), PRA1 (80) were classified in this process.
As mentioned early, this GO classification does not include ECM33, HSP70 family proteins
which, however, were usually considered as adhesins (13).

4.4.5 Monitoring putative cell wall proteins during morphogenesis of C. albicans
A SILAC based quantification approach was developed to monitor SDS-DTT extractable cell
wall associated proteins during the transition of C. albicans from yeast and hyphae. Isotopic
labeled lysine was incorporated into proteins synthesized during hyphae growth. To avoid
potential cytosolic contaminations, it was first tried to label the hyphae cell surface proteins by
sulfo-NHS-LC-biotin. However, the amount of biotinylated proteins extracted was too low for
MS analysis, and such very low labeling efficiency was probably due to the sever aggregation of
hyphae cells in PBS buffer. A classical approach to prepare cell wall pellet (66) (20) was
employed in our study. Extensive washing of the cell wall fraction by gradient concentration of
NaCl would significantly reduce cytosolic contamination; even though membrane associated
proteins would co-precipitated with cell debris as well. Hot SDS-DTT extracted CWPs were first
separated by 1D SDS-PAGE to reduce sample complexity and to increase sequence coverage.
Fifteen major bands for each biological sample were cut for in-gel digestion followed by LC-MS
and bioinformatics analyses of the tryptic peptides. A comparative analysis of those identified
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proteins was performed by using Pepquan program (incorporated in BioWorks 3.1, Thermo
Electron). The results indicted that ninety two proteins were up-regulated and twenty four
proteins were down-regulated during the morphogenesis as shown in Table 4.2. For instance,
ATP1 was slightly over-expressed in hyphae (in Figure 4.7) while expression level of ADH1 was
significantly suppressed after the germination (Figure 4.8) as evidenced by SILAC quantitative
analysis of pairs of individual peptides differentially labeled by isotopic lysine.

However, the degree of the regulation (H/L) was largely between 1.5:1 and 1:1.5 with the highest
average ratio (H/L) being 3.26 for ACC1 and the lowest ratio (H/L) being 0.21 for ADH1 as
shown in Figure 4.9, indicating that protein expression changes during the germination C.
albicans was not large. This result is in good agreement with a previous study (47). Among the
ninety two up-regulated proteins in response to germination, seven proteins (ACS2, HSP90,
PSA1, SSA, SSB1, SSE1 and TUB2.3) were previously reported as being up-regulated in a 2-D
gel based comparative analysis on SDS-DTT extracts of hyphae cells wall fraction (20). A recent
report from Gil’s group (47) also confirmed some of those proteins (ACS2, SSB1) were upregulated. Notably, five heat shock proteins (HSP90, SSA1, SSB1, SSC1, SSE1) were all
moderately up-regulated (from 1.31 to 1.51 fold) during two hour hyphae growth induced by
temperature switch from 25°C to 37°. Up-regulation of those proteins may be explained by their
primary function in heat shock protection. Similar expression level of SSB1 on yeast and hyphae
cells was first predicted based on Northern-blot analysis by Gozalbo’s group (45) and its cell
surface localization was also demonstrated by immuno-screening experiments. Previous study by
Mukai and coworkers (52) also shown that mRNA levels increased by several-fold upon
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Table 4.2 Summary of identified cell wall associated proteins (SDS-DTT extract)*
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*These identified cell wall associated proteins in SDS-DTT fraction were differentially regulated
between hyphae (H) and yeast (L) of C. albicans. Protein level up-regulated or down-regulated
by at least 1.5 fold were considered significant and displayed in bold.
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Figure 4.7 SILAC quantitative analysis of a protein extracted by SDS-DTT from cell wall pellet
of hyphae of C. albicans. This protein (ATP1) is preferentially accumulated in yeast form (A)
Part of full scan ESI mass spectrum acquired at time of 51.89 min. A peptide doublet indicated
by a solid arrow represents a pair of peptide differentially labeled by an isotopic lysine residue in
their sequence. The mass-to-charge (m/z) ratio of each peptide is 4.14 Da different. (B) Single
ion chromatograms of the paired peptides eluted from C18 column at the same time window. The
ratio (1:1.20) (H/L) calculated from peak area was used for average ratio calculation. Peptide
sequence: Peptide precursor labeled by heavy isotopes (H): m/z 883.17; peptide precursor not
labeled (L): m/z 879.03
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Figure 4.8 SILAC quantitative analysis of a protein extracted by SDS-DTT from cell wall pellet
of hyphae of C. albicans. This protein (ADH1) is preferentially accumulated in hyphal form (A)
Part of full scan mass spectrum acquired through ESI at time of 52.47 minute. A peptide doublet
indicated by a solid arrow represents a pair of peptide differentially labeled by an isotopic lysine
residue in their sequence. The mass-to-charge (m/z) ratio of each peptide is separated by 2.57
Da. (B) Single ion chromatograms of the paired peptides eluted from C18 column at the same
time window. The ratio (4.16:1) (H/L) calculated from peak area was used for average ratio
calculation. Peptide sequence: Peptide precursor labeled by heavy isotopes (H): m/z 676.78;
peptide precursor not labeled (L): m/z 674.21
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Figure 4.9. The overall graphic distribution of regulations of cell wall associated proteins during
the yeast cells morphogenesis. The detailed regulation values of proteins (dots) were listed in
Table 4.2.
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induction to hyphae growth at 37°. However, work by Brwon’s group (84) shown that HSP90
mRNA levels had no detectable increase as a result of germination. Our results suggest that there
might be an opposite correlation of expression level between mRNA and protein. Moreover, a
recent study published by Cowen’s group indicated that HSP90 played pivotal roles in regulating
temperature-dependent morphogenesis by relieving HSP90-meidated repression of other relevant
proteins through Ras1-PKA signaling cascade. (73) Compared to the larger set of up-regualated
proteins during the morphogenesis, a small group of downregulated proteins was found to be
mainly consisting of glycolysis enzymes (ADH1, PGK1, PFK2, GPM1, ENO1, CDC19). As
mentioned above, the real functions of those moonlighting proteins in the cell wall remain
enigmatic. Intriguingly, four human plasmin(ogen) binding proteins ( ENO1, ADH1, PGK1,
GPM1) were found among those down-regulated proteins, which is consistent with a previous
study (17) indicating that C. albicans cells bound to plasmin did not increase damages of
endothelial cells. Hyphae cells generally efficiently penetrate host cells through a combination
of factors that focuses hydraulic pressure at the hyphae tip via the activities of an array of
secreted hydrolases (30); and it is further evidenced by our results that some hydrolase activity
related proteins (ARF1, CEF3, HSP90, MSI3, SAP5, TIF andTFP1) are significantly upregulated. These hydrolases activity related proteins account for the highest function percentage
(17.9% ) as classified at CGD. Interestingly, work by Cutler’s group showed that only moderate
protection against candidiasis was achieved while mice were immunolized by synthetic vaccines
containing peptide fragments from down-regulated GAP1 and ENO1 (91). Their finding might
suggest that proteins highly down-regulated during the morphogenesis are presumably less
immunologically relevant in eliciting protective antibodies from the host. Moreover, we
tentatively propose IPF13485 as hyphae specific and IPF9550 as yeast specific. It should be
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noted that despite some agreement with previous reports for both up and down regulated proteins
(20) (47), our results also include proteins that showed opposite trend of regulation changes
during the germination. For instance, ATP2, EGD2 were identified to be up-regulated in our
study, but were reported as being down-regulated in a previous study (20).

Proteins with significant regulation change (out of the range between 1.5:1 and 1:1.5 as indicated
in bold type in Table 4.2 ) were classified according to their biological process by GO at CGD
(4). Most of these proteins could not be mapped due to lack of evidence reported in the literature.
Our biotinylation method confirmed the localization to cell surface of those proteins: ACC1,
ACT1, ADH1, ADH2, ALD5, CDC19, CEF3, ECM33.3, ENO1, FAS2.5f, GAD1, GAP1,
GND1, GPM1, HSP90, HXK2.3f, IPF14171, LPD1, PCK1, PDC, PET9, PGK1, POT14, QCR2,
RPL82. It was also shown in our study that ENO1 may be highly abundant in yeast cell wall
because of its largest sequence coverage (55.4%) among all identified biotinylated proteins.
Given that ENO1 was only moderately down-regulated (H/L, 1:2.23) and its low sequence
coverage (23.41%) even after 1D SDS-PAGE gel separation, we speculated that our biotinylation
labeling approach was biased toward proteins located on cell surface. The largest group for upregulated proteins (SAP5, FAS2, ECM33, LPD1, HSP90) belong to the process of interspecies
interaction between organisms and pathogenesis. Likewise down-regulated proteins (ENO1
ADH1 PGK1 GPM1 CDC19) were also classified in interspecies interaction between organisms
(including with the host). Lee’s group (14) first detected SAP4-7 proteins in culture supernatants
from hyphae cells and monitored their dynamic expression levels during different germination
stages under various pH conditions. The pathogenicity of SAPs from various C. albicans strains
was reviewed by Cassone (18). A recent review paper from Hube’s group summarized the roles

151

that secreted aspartyl proteinases (SAPs) family played in C. albicans’ interaction with host and
pointed to their direct contribution in its pathogenicity (56). Detection of SAP5 in our study
indicated that certain secreted proteins may also be non-covalently associated with cell wall and
therefore susceptible to SDS-DTT extraction. Contrary to the claim of Pinto’s group (20) that
FAS2 and LPD1was only detected from SDS-DTT resisted hyphae cell wall fraction, our result
showed that both proteins were up-regulated in hyphae cells and both also presented in yeast and
were SDS-DTT extractible. This suggests that our approach was quite sensitive in the detection
of low abundant proteins. Moreover, LPD1 were identified as labeled protein by sulfo-NHS-SSbiotin and FAS2 were also detected based on one peptide modified by I-biotin. FAS2 has also
been found in membrane-coated organelles and known for its essential role in the survival of the
yeast in non-exogenous fatty acid environment (79). Work by Nguyen’s group (15) suggested
that LPD1 could be released from cytosol to the cell surface after the cell being attacked and
damaged by the human immune system, and serve as an immunogenic antigen. Its
immunogenicity was confirmed in murine model recently by Gil’s group (24).

4.5 Conclusions
In summary, one hundred and forty eight CWPs from C. albicans yeast cell were identified
based on the detection of biotinylated peptides and observation of characteristic fragments
originated from the biotin moiety on MS2 spectra of labeled peptide. The method developed in
our study, to our knowledge, is the most accurate approach for efficient identification of CWPs
and cell wall associated proteins of C. albicans. Fifty one of one hundred forty eight proteins
were never reported before in the literature. Each approach involved with one of the three
labeling reagents has its own protein identifications, while some other protein identifications
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were shared by at least two labeling approaches even though the detected labeled peptide might
not be necessarily the same. Moreover, two hundred and thirty five cell wall-associated proteins
were identified from cell wall pellet of hyphae of C. albicans after SDS-DTT extraction.
Analyzed by this SILAC based comparative proteomic approach, ninety two proteins were
upregulated and twenty four proteins were downregulated during the transition from yeast to
hyphae growth. IPF 9550 (CA4570) and IPF 13485 (CA1019) were tentatively assigned as yeast
and hyphae specific protein respectively. Overall the expression level change ranged from 3.26
fold upregulation and 0.21 fold downregulation after the morphological transition from yeast to
hyphae. Thirty nine proteins were significantly upregulated (more than 1.5 fold increase) and
thirteen proteins were significantly downregualted (more than 1.5 fold decrease) in hyphae cells.
According to the functional classification obtained from CGD, seven upregulated proteins were
related to hydrolase enzymatic activities which might be promoted in cell wall during
germination, while four major plasmin(ogen) binding proteins were downregulated possibly to
facilitate germ tube elongation. This extensive study on cell surface proteome analysis of C.
albicans will help elucidate the mechanism of host-pathogen interaction and guide in protective
vaccine development in future.
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Note: K& indicates that lysine residue was labeled by sulfo-NHS-LC-biotin. K+ indicates that
lysine residue was labeled by sulfo-NHS-SS-biotin. C# indicates that cysteine residue was
labeled by iodoacetyl-PEO2-biotin. C@ shows that cysteine residue was modified by IA before
trypsin digestion. M* shows that methionine was oxidized. Green highlighted proteins were
those reported for the first time.
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